,active_ingredient_moiety,nda_bla,approval_year,active,DrugBank ID,Drug Groups,SMILES
0,troglitazone,NDA,1997,troglitazone,DB00197,approved; investigational; withdrawn,CC1=C(C)C2=C(CCC(C)(COC3=CC=C(CC4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
1,imiquimod,NDA,1997,imiquimod,DB00724,approved; investigational,CC(C)CN1C=NC2=C1C1=C(C=CC=C1)N=C2N
2,anagrelide hydrochloride,NDA,1997,anagrelide,DB00261,approved,ClC1=CC=C2N=C3NC(=O)CN3CC2=C1Cl
3,nelfinavir mesylate,NDA,1997,nelfinavir,DB00220,approved,[H][C@@]12CCCC[C@]1([H])CN(C[C@@H](O)[C@H](CSC1=CC=CC=C1)NC(=O)C1=C(C)C(O)=CC=C1)[C@@H](C2)C(=O)NC(C)(C)C
4,delavirdine mesylate,NDA,1997,delavirdine,DB00705,approved,CC(C)NC1=C(N=CC=C1)N1CCN(CC1)C(=O)C1=CC2=C(N1)C=CC(NS(C)(=O)=O)=C2
5,tamsulosin hydrochloride,NDA,1997,tamsulosin,DB00706,approved; investigational,CCOC1=CC=CC=C1OCCN[C@H](C)CC1=CC(=C(OC)C=C1)S(N)(=O)=O
6,toremifene citrate,NDA,1997,toremifene,DB00539,approved; investigational,CN(C)CCOC1=CC=C(C=C1)C(=C(\CCCl)C1=CC=CC=C1)\C1=CC=CC=C1
7,tazarotene,NDA,1997,tazarotene,DB00799,approved; investigational,CCOC(=O)C1=CN=C(C=C1)C#CC1=CC2=C(SCCC2(C)C)C=C1
8,cerivastatin sodium,NDA,1997,cerivastatin,DB00439,approved; withdrawn,COCC1=C(C2=CC=C(F)C=C2)C(\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)=C(C(C)C)N=C1C(C)C
9,pramipexole dihydrochloride,NDA,1997,pramipexole,DB00413,approved; investigational,CCCN[C@H]1CCC2=C(C1)SC(N)=N2
10,bromfenac sodium,NDA,1997,bromfenac,DB00963,approved,NC1=C(CC(O)=O)C=CC=C1C(=O)C1=CC=C(Br)C=C1
11,letrozole,NDA,1997,letrozole,DB01006,approved; investigational,N#CC1=CC=C(C=C1)C(N1C=NC=N1)C1=CC=C(C=C1)C#N
12,dolasetron mesylate,NDA,1997,dolasetron,DB00757,approved; investigational,[H][C@@]1(C[C@@]2([H])C[C@]3([H])C[C@@]([H])(C1)N2CC3=O)OC(=O)C1=CNC2=C1C=CC=C2
13,arbutamine hydrochloride,NDA,1997,arbutamine,DB01102,approved,O[C@@H](CNCCCCC1=CC=C(O)C=C1)C1=CC(O)=C(O)C=C1
14,ropinirole hydrochloride,NDA,1997,ropinirole,DB00268,approved; investigational,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
15,fenoldopam mesylate,NDA,1997,fenoldopam,DB00800,approved,OC1=CC=C(C=C1)C1CNCCC2=C(Cl)C(O)=C(O)C=C12
16,quetiapine fumarate,NDA,1997,quetiapine,DB01224,approved,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
17,tiagabine hydrochloride,NDA,1997,tiagabine,DB00906,approved; investigational,CC1=C(SC=C1)C(=CCCN1CCC[C@H](C1)C(O)=O)C1=C(C)C=CS1
18,irbesartan,NDA,1997,irbesartan,DB01029,approved; investigational,CCCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1
19,grepafloxacin hydrochloride,NDA,1997,grepafloxacin,DB00365,approved; investigational; withdrawn,CC1CN(CCN1)C1=C(F)C(C)=C2C(=O)C(=CN(C3CC3)C2=C1)C(O)=O
20,clopidogrel bisulfate,NDA,1997,clopidogrel,DB00758,approved,[H][C@@](N1CCC2=C(C1)C=CS2)(C(=O)OC)C1=CC=CC=C1Cl
21,sibutramine hydrochloride,NDA,1997,sibutramine,DB01105,approved; illicit; investigational; withdrawn,CC(C)CC(N(C)C)C1(CCC1)C1=CC=C(Cl)C=C1
22,zolmitriptan,NDA,1997,zolmitriptan,DB00315,approved; investigational,CN(C)CCC1=CNC2=CC=C(C[C@H]3COC(=O)N3)C=C12
23,mangafodipir trisodium,NDA,1997,mangafodipir,DB06796,approved; investigational; withdrawn,[Mn++].CC1=C(O)C(CN(CCN(CC([O-])=O)CC2=CC(COP(O)(O)=O)=NC(C)=C2O)CC([O-])=O)=CC(COP(O)(O)=O)=N1
24,cefdinir,NDA,1997,cefdinir,DB00535,approved,[H][C@]12SCC(C=C)=C(N1C(=O)[C@H]2NC(=O)C(=N/O)\C1=CSC(N)=N1)C(O)=O
25,fomepizole,NDA,1997,fomepizole,DB01213,approved; vet_approved,CC1=CNN=C1
26,raloxifene hydrochloride,NDA,1997,raloxifene,DB00481,approved; investigational,OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2
27,alatrofloxacin mesylate,NDA,1997,alatrofloxacin,DB09335,approved; withdrawn,[H][C@@]12CN(C[C@]1([H])[C@H]2NC(=O)[C@H](C)NC(=O)[C@H](C)N)C1=NC2=C(C=C1F)C(=O)C(=CN2C1=CC=C(F)C=C1F)C(O)=O
28,trovafloxacin mesylate,NDA,1997,trovafloxacin,DB00685,approved; investigational; withdrawn,[H][C@@]12CN(C[C@]1([H])[C@H]2N)C1=NC2=C(C=C1F)C(=O)C(=CN2C1=C(F)C=C(F)C=C1)C(O)=O
29,eprosartan mesylate,NDA,1997,eprosartan,DB00876,approved,CCCCC1=NC=C(\C=C(/CC2=CC=CS2)C(O)=O)N1CC1=CC=C(C=C1)C(O)=O
30,repaglinide,NDA,1997,repaglinide,DB00912,approved; investigational,CCOC1=C(C=CC(CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N2CCCCC2)=C1)C(O)=O
31,talc,NDA,1997,talc,DB09511,approved,[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[Mg++].[Mg++].[Mg++].[Si+4].[Si+4].[Si+4].[Si+4].[O-][H].[O-][H]
32,emedastine difumarate,NDA,1997,emedastine,DB01084,approved,CCOCCN1C(=NC2=CC=CC=C12)N1CCCN(C)CC1
33,tolcapone,NDA,1998,tolcapone,DB00323,approved; withdrawn,CC1=CC=C(C=C1)C(=O)C1=CC(=C(O)C(O)=C1)[N+]([O-])=O
34,naratriptan,NDA,1998,naratriptan,DB00952,approved; investigational,CNS(=O)(=O)CCC1=CC2=C(NC=C2C2CCN(C)CC2)C=C1
35,montelukast sodium,NDA,1998,montelukast,DB00471,approved,OC(=O)CC1(CC1)CS[C@H](CCC1=CC=CC=C1C(O)(C)C)C1=CC=CC(\C=C\C2=NC3=C(C=CC(Cl)=C3)C=C2)=C1
36,loteprednol etabonate,NDA,1998,loteprednol etabonate,DB14596,approved,[H][C@@]12CC[C@](OC(=O)OCC)(C(=O)OCCl)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C
37,tolterodine tartrate,NDA,1998,tolterodine,DB01036,approved; investigational,CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(O)C=CC(C)=C1)C(C)C
38,sildenafil citrate,NDA,1998,sildenafil,DB00203,approved; investigational,CCCC1=NN(C)C2=C1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(C)CC1
39,brinzolamide,NDA,1998,brinzolamide,DB01194,approved,CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
40,paricalcitol,NDA,1998,paricalcitol,DB00910,approved; investigational,[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1C[C@@H](O)C[C@H](O)C1)[C@H](C)\C=C\[C@H](C)C(C)(C)O
41,capecitabine,NDA,1998,capecitabine,DB01101,approved; investigational,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O
42,tirofiban hydrochloride,NDA,1998,tirofiban,DB00775,approved,CCCCS(=O)(=O)N[C@@H](CC1=CC=C(OCCCCC2CCNCC2)C=C1)C(O)=O
43,rifapentine,NDA,1998,rifapentine,DB01201,approved; investigational,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(C(O)=C3C)C(O)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(\C=N\N1CCN(CC1)C1CCCC1)=C2O
44,rizatriptan benzoate,NDA,1998,rizatriptan,DB00953,approved,CN(C)CCC1=CNC2=C1C=C(CN1C=NC=N1)C=C2
45,thalidomide,NDA,1998,thalidomide,DB01041,approved; investigational; withdrawn,O=C1N(C2CCC(=O)NC2=O)C(=O)C2=CC=CC=C12
46,citalopram hydrobromide,NDA,1998,citalopram,DB00215,approved,CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1
47,leflunomide,NDA,1998,leflunomide,DB01097,approved; investigational,CC1=C(C=NO1)C(=O)NC1=CC=C(C=C1)C(F)(F)F
48,efavirenz,NDA,1998,efavirenz,DB00625,approved; investigational,FC(F)(F)[C@]1(OC(=O)NC2=C1C=C(Cl)C=C2)C#CC1CC1
49,valrubicin,NDA,1998,valrubicin,DB00385,approved,[H][C@@]1(C[C@@](O)(CC2=C(O)C3=C(C(O)=C12)C(=O)C1=C(OC)C=CC=C1C3=O)C(=O)COC(=O)CCCC)O[C@H]1C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O1
50,sevelamer hydrochloride,NDA,1998,sevelamer,DB00658,approved,NCC=C.ClCC1CO1
51,telmisartan,NDA,1998,telmisartan,DB00966,approved; investigational,CCCC1=NC2=C(C=C(C=C2C)C2=NC3=CC=CC=C3N2C)N1CC1=CC=C(C=C1)C1=CC=CC=C1C(O)=O
52,abacavir sulfate,NDA,1998,abacavir,DB01048,approved; investigational,NC1=NC2=C(N=CN2[C@@H]2C[C@H](CO)C=C2)C(NC2CC2)=N1
53,modafinil,NDA,1998,modafinil,DB00745,approved; investigational,NC(=O)CS(=O)C(C1=CC=CC=C1)C1=CC=CC=C1
54,celecoxib,NDA,1998,celecoxib,DB00482,approved; investigational,CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F
55,cilostazol,NDA,1999,cilostazol,DB01166,approved; investigational,O=C1CCC2=C(N1)C=CC(OCCCCC1=NN=NN1C1CCCCC1)=C2
56,alitretinoin,NDA,1999,alitretinoin,DB00523,approved; investigational,C\C(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(\C)=C\C(O)=O
57,amprenavir,NDA,1999,amprenavir,DB00701,approved; investigational,CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)C1=CC=C(N)C=C1
58,orlistat,NDA,1999,orlistat,DB01083,approved; investigational,CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O
59,rofecoxib,NDA,1999,rofecoxib,DB00533,approved; investigational; withdrawn,CS(=O)(=O)C1=CC=C(C=C1)C1=C(C(=O)OC1)C1=CC=CC=C1
60,rosiglitazone maleate,NDA,1999,rosiglitazone,DB00412,approved; investigational,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1
61,doxercalciferol,NDA,1999,doxercalciferol,DB06410,approved,[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)[C@H](C)\C=C\[C@H](C)C(C)C
62,ketotifen fumarate,NDA,1999,ketotifen,DB00920,approved,CN1CCC(CC1)=C1C2=C(SC=C2)C(=O)CC2=CC=CC=C12
63,pioglitazone hydrochloride,NDA,1999,pioglitazone,DB01132,approved; investigational,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1
64,zanamivir,NDA,1999,zanamivir,DB00558,approved; investigational,[H][C@]1(OC(=C[C@H](N=C(N)N)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO
65,ganirelix acetate,NDA,1999,ganirelix,DB06785,approved,CCNC(NCC)=NCCCC[C@@H](NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@@H](CC1=CC=CN=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC2=CC=CC=C2C=C1)NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN=C(NCC)NCC)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O
66,temozolomide,NDA,1999,temozolomide,DB00853,approved; investigational,CN1N=NC2=C(N=CN2C1=O)C(N)=O
67,zaleplon,NDA,1999,zaleplon,DB00962,approved; illicit; investigational,CCN(C(C)=O)C1=CC=CC(=C1)C1=CC=NC2=C(C=NN12)C#N
68,rapacuronium bromide,NDA,1999,rapacuronium,DB04834,approved; withdrawn,[H][C@@]12C[C@@H]([C@H](OC(=O)CC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)N1CCCCC1)[N+]1(CC=C)CCCCC1
69,rabeprazole sodium,NDA,1999,rabeprazole,DB01129,approved; investigational,COCCCOC1=C(C)C(CS(=O)C2=NC3=CC=CC=C3N2)=NC=C1
70,epirubicin hydrochloride,NDA,1999,epirubicin,DB00445,approved,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@@H](O)[C@H](C)O3)C(=O)CO)C(O)=C1C2=O
71,sirolimus,NDA,1999,sirolimus,DB00877,approved; investigational,[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)OC)CC[C@@H](O)[C@@H](C1)OC
72,dofetilide,NDA,1999,dofetilide,DB00204,approved; investigational,CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC1=CC=C(NS(C)(=O)=O)C=C1
73,entacapone,NDA,1999,entacapone,DB00494,approved; investigational,CCN(CC)C(=O)C(=C\C1=CC(=C(O)C(O)=C1)[N+]([O-])=O)\C#N
74,exemestane,NDA,1999,exemestane,DB00990,approved; investigational,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC(=C)C2=CC(=O)C=C[C@]12C
75,oseltamivir phosphate,NDA,1999,oseltamivir,DB00198,approved,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1
76,levetiracetam,NDA,1999,levetiracetam,DB01202,approved,CC[C@H](N1CCCC1=O)C(N)=O
77,aminolevulinic acid hydrochloride,NDA,1999,aminolevulinic acid,DB00855,approved,NCC(=O)CCC(O)=O
78,gadoversetamide,NDA,1999,gadoversetamide,DB00538,approved; investigational,[Gd+3].COCCNC(=O)CN(CCN(CCN(CC([O-])=O)CC(=O)NCCOC)CC([O-])=O)CC([O-])=O
79,moxifloxacin hydrochloride,NDA,1999,moxifloxacin,DB00218,approved; investigational,[H][C@]12CN(C[C@@]1([H])NCCC2)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=C1OC)C(O)=O
80,dexmedetomidine hydrochloride,NDA,1999,dexmedetomidine,DB00633,approved; vet_approved,C[C@H](C1=CNC=N1)C1=C(C)C(C)=CC=C1
81,gatifloxacin,NDA,1999,gatifloxacin,DB01044,approved; investigational,COC1=C2N(C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNC(C)C1)C1CC1
82,nitric oxide,NDA,1999,nitric oxide,DB00435,approved,[N]=O
83,bexarotene,NDA,1999,bexarotene,DB00307,approved; investigational,CC1=CC2=C(C=C1C(=C)C1=CC=C(C=C1)C(O)=O)C(C)(C)CCC2(C)C
84,cevimeline hydrochloride,NDA,2000,cevimeline,DB00185,approved,CC1O[C@@]2(CS1)CN1CCC2CC1
85,oxcarbazepine,NDA,2000,oxcarbazepine,DB00776,approved,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2
86,pantoprazole sodium,NDA,2000,pantoprazole,DB00213,approved,COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1
87,alosetron hydrochloride,NDA,2000,alosetron,DB00969,approved; withdrawn,CN1C2=C(C3=CC=CC=C13)C(=O)N(CC1=C(C)NC=N1)CC2
88,zonisamide,NDA,2000,zonisamide,DB00909,approved; investigational,NS(=O)(=O)CC1=NOC2=CC=CC=C12
89,verteporfin,NDA,2000,verteporfin,DB00460,approved; investigational,COC(=O)CCC1=C2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(CCC(O)=O)=C5C)C(C=C)=C4C)C2=CC=C([C@@H](C(=O)OC)[C@@]32C)C(=O)OC)=C1C
90,meloxicam,NDA,2000,meloxicam,DB00814,approved; vet_approved,CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C2=C(C=CC=C2)S1(=O)=O
91,linezolid,NDA,2000,linezolid,DB00601,approved; investigational,CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC(F)=C(C=C1)N1CCOCC1
92,rivastigmine tartrate,NDA,2000,rivastigmine,DB00989,approved; investigational,CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C
93,argatroban,NDA,2000,argatroban,DB00278,approved; investigational,C[C@@H]1CCN([C@H](C1)C(O)=O)C(=O)[C@H](CCCNC(N)=N)NS(=O)(=O)C1=CC=CC2=C1NCC(C)C2
94,balsalazide disodium,NDA,2000,balsalazide,DB01014,approved; investigational,OC(=O)CCNC(=O)C1=CC=C(C=C1)\N=N\C1=CC=C(O)C(=C1)C(O)=O
95,docosanol,NDA,2000,docosanol,DB00632,approved; investigational,CCCCCCCCCCCCCCCCCCCCCCO
96,cetrorelix acetate,NDA,2000,cetrorelix,DB00050,approved; investigational,CC(C)C[C@H](NC(=O)[C@@H](CCCNC(N)=O)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@@H](CC1=CN=CC=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC2=CC=CC=C2C=C1)NC(C)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O
97,arsenic trioxide,NDA,2000,arsenic trioxide,DB01169,approved; investigational,O=[As]O[As]=O
98,mifepristone,NDA,2000,mifepristone,DB00834,approved; investigational,[H][C@@]12CC[C@@](O)(C#CC)[C@@]1(C)C[C@H](C1=CC=C(C=C1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@]21[H]
99,bivalirudin,NDA,2000,bivalirudin,DB00006,approved; investigational,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O
100,nateglinide,NDA,2000,nateglinide,DB00731,approved; investigational,CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@H](CC1=CC=CC=C1)C(O)=O
101,caspofungin acetate,NDA,2001,caspofungin,DB00520,approved,[H][C@@]12C[C@@H](O)CN1C(=O)[C@@H](NC(=O)[C@]([H])(C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]1[C@@H](O)CCN1C(=O)[C@@H](NC(=O)[C@@H](NC2=O)[C@H](O)[C@@H](O)C1=CC=C(O)C=C1)[C@H](O)CCN)NC(=O)CCCCCCCC[C@@H](C)C[C@@H](C)CC)[C@@H](C)O
102,ziprasidone hydrochloride,NDA,2001,ziprasidone,DB00246,approved,ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1
103,formoterol fumarate,NDA,2001,formoterol,DB00983,approved; investigational,COC1=CC=C(CC(C)NCC(O)C2=CC(NC=O)=C(O)C=C2)C=C1
104,galantamine hydrobromide,NDA,2001,galantamine,DB00674,approved,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3
105,travoprost,NDA,2001,travoprost,DB00287,approved,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COC1=CC=CC(=C1)C(F)(F)F
106,bimatoprost,NDA,2001,bimatoprost,DB00905,approved; investigational,CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC1=CC=CC=C1
107,almotriptan malate,NDA,2001,almotriptan,DB00918,approved; investigational,CN(C)CCC1=CNC2=C1C=C(CS(=O)(=O)N1CCCC1)C=C2
108,imatinib mesylate,NDA,2001,imatinib,DB00619,approved,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1
109,zoledronic acid,NDA,2001,zoledronic acid,DB00399,approved,OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O
110,tenofovir disoproxil fumarate,NDA,2001,tenofovir disoproxil,DB00300,approved; investigational,[H][C@@](C)(CN1C=NC2=C(N)N=CN=C12)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C
111,frovatriptan,NDA,2001,frovatriptan,DB00998,approved; investigational,CN[C@@H]1CCC2=C(C1)C1=C(N2)C=CC(=C1)C(N)=O
112,valdecoxib,NDA,2001,valdecoxib,DB00580,approved; investigational; withdrawn,CC1=C(C(=NO1)C1=CC=CC=C1)C1=CC=C(C=C1)S(N)(=O)=O
113,dutasteride,NDA,2001,dutasteride,DB01126,approved; investigational,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])NC(=O)C=C[C@]4(C)[C@@]3([H])CC[C@]12C)C(=O)NC1=CC(=CC=C1C(F)(F)F)C(F)(F)F
114,bosentan,NDA,2001,bosentan,DB00559,approved; investigational,COC1=CC=CC=C1OC1=C(NS(=O)(=O)C2=CC=C(C=C2)C(C)(C)C)N=C(N=C1OCCO)C1=NC=CC=N1
115,ertapenem sodium,NDA,2001,ertapenem,DB00303,approved; investigational,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@@]([H])(C3)C(=O)NC3=CC=CC(=C3)C(O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O
116,fondaparinux sodium,NDA,2001,fondaparinux,DB00569,approved; investigational,CO[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](O[C@@H]2O[C@H]([C@@H](O[C@H]3O[C@H](COS(O)(=O)=O)[C@@H](O[C@@H]4O[C@@H]([C@@H](O[C@H]5O[C@H](COS(O)(=O)=O)[C@@H](O)[C@H](O)[C@H]5NS(O)(=O)=O)[C@H](O)[C@H]4O)C(O)=O)[C@H](OS(O)(=O)=O)[C@H]3NS(O)(=O)=O)[C@H](O)[C@H]2OS(O)(=O)=O)C(O)=O)[C@H](O)[C@H]1NS(O)(=O)=O
117,pimecrolimus,NDA,2001,pimecrolimus,DB00337,approved; investigational,[H][C@]1(CC[C@H](Cl)[C@@H](C1)OC)\C=C(/C)[C@@]1([H])OC(=O)[C@]2([H])CCCCN2C(=O)C(=O)[C@]2(O)O[C@@]([H])([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC)C(=O)C[C@H](O)[C@H]1C)OC
118,desloratadine,NDA,2001,desloratadine,DB00967,approved; investigational,ClC1=CC2=C(C=C1)C(=C1CCNCC1)C1=C(CC2)C=CC=N1
119,nitisinone,NDA,2002,nitisinone,DB00348,approved; investigational,[O-][N+](=O)C1=C(C=CC(=C1)C(F)(F)F)C(=O)C1C(=O)CCCC1=O
120,fulvestrant,NDA,2002,fulvestrant,DB00947,approved; investigational,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@@]21[H]
121,treprostinil sodium,NDA,2002,treprostinil,DB00374,approved; investigational,[H][C@]12C[C@@H](O)[C@H](CC[C@@H](O)CCCCC)[C@@]1([H])CC1=C(C2)C(OCC(O)=O)=CC=C1
122,voriconazole,NDA,2002,voriconazole,DB00582,approved,C[C@@H](C1=NC=NC=C1F)[C@](O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1
123,tegaserod maleate,NDA,2002,tegaserod,DB01079,approved; investigational; withdrawn,CCCCCNC(=N)N\N=C\C1=CNC2=C1C=C(OC)C=C2
124,oxaliplatin,NDA,2002,oxaliplatin,DB00526,approved; investigational,[H][N]1([H])[C@@H]2CCCC[C@H]2[N]([H])([H])[Pt]11OC(=O)C(=O)O1
125,adefovir dipivoxil,NDA,2002,adefovir dipivoxil,DB00718,approved; investigational,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N)N=CN=C12)OCOC(=O)C(C)(C)C
126,eplerenone,NDA,2002,eplerenone,DB00700,approved,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)C[C@H]1O[C@@]11[C@@]2([H])[C@@H](CC2=CC(=O)CC[C@]12C)C(=O)OC
127,ezetimibe,NDA,2002,ezetimibe,DB00973,approved,[H][C@]1(CC[C@H](O)C2=CC=C(F)C=C2)C(=O)N(C2=CC=C(F)C=C2)[C@]1([H])C1=CC=C(O)C=C1
128,aripiprazole,NDA,2002,aripiprazole,DB01238,approved; investigational,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl
129,nitazoxanide,NDA,2002,nitazoxanide,DB00507,approved; investigational; vet_approved,CC(=O)OC1=CC=CC=C1C(=O)NC1=NC=C(S1)[N+]([O-])=O
130,atomoxetine hydrochloride,NDA,2002,atomoxetine,DB00289,approved,CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1
131,eletriptan hydrobromide,NDA,2002,eletriptan,DB00216,approved; investigational,CN1CCC[C@@H]1CC1=CNC2=C1C=C(CCS(=O)(=O)C1=CC=CC=C1)C=C2
132,aprepitant,NDA,2003,aprepitant,DB00673,approved; investigational,C[C@@H](O[C@H]1OCCN(CC2=NNC(=O)N2)[C@H]1C1=CC=C(F)C=C1)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F
133,gemifloxacin mesylate,NDA,2003,gemifloxacin,DB01155,approved; investigational,CO\N=C1/CN(CC1CN)C1=NC2=C(C=C1F)C(=O)C(=CN2C1CC1)C(O)=O
134,gefitinib,NDA,2003,gefitinib,DB00317,approved; investigational,COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
135,bortezomib,NDA,2003,bortezomib,DB00188,approved; investigational,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O
136,alfuzosin hydrochloride,NDA,2003,alfuzosin,DB00346,approved; investigational,COC1=CC2=C(C=C1OC)C(N)=NC(=N2)N(C)CCCNC(=O)C1CCCO1
137,atazanavir sulfate,NDA,2003,atazanavir,DB01072,approved; investigational,COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C
138,emtricitabine,NDA,2003,emtricitabine,DB00879,approved; investigational,NC1=NC(=O)N(C=C1F)[C@@H]1CS[C@H](CO)O1
139,palonosetron hydrochloride,NDA,2003,palonosetron,DB00377,approved; investigational,[H][C@]12CCCC3=C1C(=CC=C3)C(=O)N(C2)[C@@H]1CN2CCC1CC2
140,miglustat,NDA,2003,miglustat,DB00419,approved,CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO
141,rosuvastatin calcium,NDA,2003,rosuvastatin,DB01098,approved,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(=O)O)N(C)S(C)(=O)=O
142,vardenafil hydrochloride,NDA,2003,vardenafil,DB00862,approved,CCCC1=NC(C)=C2N1NC(=NC2=O)C1=C(OCC)C=CC(=C1)S(=O)(=O)N1CCN(CC)CC1
143,daptomycin,NDA,2003,daptomycin,DB00080,approved; investigational,CCCCCCCCCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H]1[C@@H](C)OC(=O)[C@H](CC(=O)C2=CC=CC=C2N)NC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCN)NC(=O)CNC1=O)[C@H](C)CC(O)=O
144,prussian blue,NDA,2003,prussian blue,DB06783,approved,[Fe+3].[Fe+3].[Fe+3].[Fe+3].N#C[Fe-4](C#N)(C#N)(C#N)(C#N)C#N.N#C[Fe-4](C#N)(C#N)(C#N)(C#N)C#N.N#C[Fe-4](C#N)(C#N)(C#N)(C#N)C#N
145,epinastine hydrochloride,NDA,2003,epinastine,DB00751,approved; investigational,NC1=NCC2N1C1=CC=CC=C1CC1=CC=CC=C21
146,memantine hydrochloride,NDA,2003,memantine,DB01043,approved; investigational,CC12CC3CC(C)(C1)CC(N)(C3)C2
147,tadalafil,NDA,2003,tadalafil,DB00820,approved; investigational,[H][C@]12CC3=C(NC4=CC=CC=C34)[C@H](N1C(=O)CN(C)C2=O)C1=CC2=C(OCO2)C=C1
148,abarelix,NDA,2003,abarelix,DB00106,approved; investigational; withdrawn,CC(C)C[C@H](NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](CC1=CC=C(O)C=C1)N(C)C(=O)[C@H](CO)NC(=O)[C@@H](CC1=CN=CC=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC2=C(C=CC=C2)C=C1)NC(C)=O)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O
149,sertaconazole nitrate,NDA,2003,sertaconazole,DB01153,approved; investigational,ClC1=CC(Cl)=C(C=C1)C(CN1C=CN=C1)OCC1=CSC2=C1C=CC=C2Cl
150,tiotropium bromide,NDA,2004,tiotropium,DB01409,approved,[H][C@]12O[C@@]1([H])[C@]1([H])C[C@@]([H])(C[C@@]2([H])[N+]1(C)C)OC(=O)C(O)(C1=CC=CS1)C1=CC=CS1
151,pemetrexed disodium,NDA,2004,pemetrexed,DB00642,approved; investigational,NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1
152,cinacalcet hydrochloride,NDA,2004,cinacalcet,DB01012,approved,C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=CC=CC=C12
153,telithromycin,NDA,2004,telithromycin,DB00976,approved,[H][C@@]12[C@@H](C)C(=O)[C@H](C)C[C@@](C)(OC)[C@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@H](C)C(=O)[C@@H](C)C(=O)O[C@H](CC)[C@@]1(C)OC(=O)N2CCCCN1C=NC(=C1)C1=CC=CN=C1
154,apomorphine hydrochloride,NDA,2004,apomorphine,DB00714,approved; investigational,[H][C@]12CC3=C(C(O)=C(O)C=C3)C3=CC=CC(CCN1C)=C23
155,tinidazole,NDA,2004,tinidazole,DB00911,approved; investigational,CCS(=O)(=O)CCN1C(C)=NC=C1[N+]([O-])=O
156,azacitidine,NDA,2004,azacitidine,DB00928,approved; investigational,NC1=NC(=O)N(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
157,rifaximin,NDA,2004,rifaximin,DB01220,approved; investigational,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C)C(O)=C4C(O)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C1=C(N=C5C=C(C)C=CN15)C4=C3C2=O
158,trospium chloride,NDA,2004,trospium,DB00209,approved,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)[N+]21CCCC1
159,l-glutamine,NDA,2004,l-glutamine,DB00130,approved; investigational; nutraceutical,N[C@@H](CCC(N)=O)C(O)=O
160,acamprosate calcium,NDA,2004,acamprosate,DB00659,approved; investigational,CC(=O)NCCCS(O)(=O)=O
161,duloxetine hydrochloride,NDA,2004,duloxetine,DB00476,approved,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1
162,erlotinib hydrochloride,NDA,2004,erlotinib,DB00530,approved; investigational,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2
163,solifenacin succinate,NDA,2004,solifenacin,DB01591,approved,O=C(O[C@H]1CN2CCC1CC2)N1CCC2=CC=CC=C2[C@@H]1C1=CC=CC=C1
164,eszopiclone,NDA,2004,eszopiclone,DB00402,approved; investigational,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1
165,darifenacin hydrobromide,NDA,2004,darifenacin,DB00496,approved; investigational,NC(=O)C([C@@H]1CCN(CCC2=CC3=C(OCC3)C=C2)C1)(C1=CC=CC=C1)C1=CC=CC=C1
166,ziconotide,NDA,2004,ziconotide,DB06283,approved,[H][C@]12CSSC[C@]3([H])NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CSSC[C@]([H])(NC(=O)[C@]([H])(CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC1=O)C(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC3=O)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N2
167,iloprost,NDA,2004,iloprost,DB01088,approved; investigational,[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)C(C)CC#CC)[C@@]1([H])C\C(C2)=C\CCCC(O)=O
168,pregabalin,NDA,2004,pregabalin,DB00230,approved; investigational,CC(C)C[C@H](CN)CC(O)=O
169,pramlintide acetate,NDA,2005,pramlintide,DB01278,approved; investigational,[H]N[C@@H](CCCCN)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@]([H])(NC(=O)[C@H](C)NC(=O)[C@@]([H])(NC(=O)[C@H](CC(N)=O)NC1=O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@]([H])([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(N)=O
170,micafungin sodium,NDA,2005,micafungin,DB01141,approved; investigational,CCCCCOC1=CC=C(C=C1)C1=CC(=NO1)C1=CC=C(C=C1)C(=O)N[C@H]1C[C@@H](O)[C@@H](O)NC(=O)[C@@H]2[C@@H](O)[C@@H](C)CN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC1=O)[C@@H](C)O)[C@H](O)[C@@H](O)C1=CC(OS(O)(=O)=O)=C(O)C=C1)[C@H](O)CC(N)=O
171,entecavir,NDA,2005,entecavir,DB00442,approved; investigational,NC1=NC(=O)C2=C(N1)N(C=N2)[C@H]1C[C@H](O)[C@@H](CO)C1=C
172,tigecycline,NDA,2005,tigecycline,DB00560,approved,[H][C@@]12CC3=C(C(O)=C(NC(=O)CNC(C)(C)C)C=C3N(C)C)C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2
173,tipranavir,NDA,2005,tipranavir,DB00932,approved; investigational,[H][C@@](CC)(C1=CC(NS(=O)(=O)C2=NC=C(C=C2)C(F)(F)F)=CC=C1)C1=C(O)C[C@@](CCC)(CCC2=CC=CC=C2)OC1=O
174,ramelteon,NDA,2005,ramelteon,DB00980,approved; investigational,CCC(=O)NCC[C@@H]1CCC2=C1C1=C(OCC1)C=C2
175,nepafenac,NDA,2005,nepafenac,DB06802,approved; investigational,NC(=O)CC1=CC=CC(C(=O)C2=CC=CC=C2)=C1N
176,nelarabine,NDA,2005,nelarabine,DB01280,approved; investigational,COC1=NC(N)=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O
177,deferasirox,NDA,2005,deferasirox,DB01609,approved; investigational,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O
178,sorafenib tosylate,NDA,2005,sorafenib,DB00398,approved; investigational,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1
179,lenalidomide,NDA,2005,lenalidomide,DB00480,approved,NC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O
180,conivaptan hydrochloride,NDA,2005,conivaptan,DB00872,approved; investigational,CC1=NC2=C(CCN(C(=O)C3=CC=C(NC(=O)C4=CC=CC=C4C4=CC=CC=C4)C=C3)C3=CC=CC=C23)N1
181,sunitinib malate,NDA,2006,sunitinib,DB01268,approved; investigational,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C
182,ranolazine,NDA,2006,ranolazine,DB00243,approved; investigational,COC1=CC=CC=C1OCC(O)CN1CCN(CC(=O)NC2=C(C)C=CC=C2C)CC1
183,lubiprostone,NDA,2006,lubiprostone,DB01046,approved; investigational,[H][C@@]12CC(=O)[C@H](CCCCCCC(O)=O)[C@@]1([H])CC[C@@](O)(O2)C(F)(F)CCCC
184,anidulafungin,NDA,2006,anidulafungin,DB00362,approved; investigational,[H][C@]1(NC(=O)[C@@H](NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)[C@H](C[C@@H](O)[C@@H](O)NC(=O)[C@@H]2[C@@H](O)[C@@H](C)CN2C1=O)NC(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)C1=CC=C(OCCCCC)C=C1)[C@@H](C)O)[C@H](O)[C@@H](O)C1=CC=C(O)C=C1)[C@@H](C)O
185,decitabine,NDA,2006,decitabine,DB01262,approved; investigational,NC1=NC(=O)N(C=N1)[C@H]1C[C@H](O)[C@@H](CO)O1
186,varenicline,NDA,2006,varenicline,DB01273,approved; investigational,C1C2CNCC1C1=C2C=C2N=CC=NC2=C1
187,rasagiline mesylate,NDA,2006,rasagiline,DB01367,approved,C#CCN[C@@H]1CCC2=CC=CC=C12
188,darunavir,NDA,2006,darunavir,DB01264,approved,[H][C@@]12CCO[C@]1([H])OC[C@@H]2OC(=O)N[C@@H](CC1=CC=CC=C1)[C@H](O)CN(CC(C)C)S(=O)(=O)C1=CC=C(N)C=C1
189,dasatinib,NDA,2006,dasatinib,DB01254,approved; investigational,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
190,posaconazole,NDA,2006,posaconazole,DB01263,approved; investigational; vet_approved,CC[C@@H]([C@H](C)O)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@@H]2CO[C@](CN3C=NC=N3)(C2)C2=C(F)C=C(F)C=C2)C=C1
191,vorinostat,NDA,2006,vorinostat,DB02546,approved; investigational,ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1
192,sitagliptin phosphate,NDA,2006,sitagliptin,DB01261,approved; investigational,N[C@@H](CC(=O)N1CCN2C(C1)=NN=C2C(F)(F)F)CC1=CC(F)=C(F)C=C1F
193,ciclesonide,NDA,2006,ciclesonide,DB01410,approved; investigational,[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(O[C@@H](O2)C1CCCCC1)C(=O)COC(=O)C(C)C
194,telbivudine,NDA,2006,telbivudine,DB01265,approved; investigational,CC1=CN([C@@H]2C[C@@H](O)[C@H](CO)O2)C(=O)NC1=O
195,paliperidone,NDA,2006,paliperidone,DB01267,approved,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1
196,lisdexamfetamine dimesylate,NDA,2007,lisdexamfetamine,DB01255,approved; investigational,C[C@@H](CC1=CC=CC=C1)NC(=O)[C@@H](N)CCCCN
197,aliskiren,NDA,2007,aliskiren,DB09026,approved; investigational,COCCCOC1=C(OC)C=CC(C[C@@H](C[C@H](N)[C@@H](O)C[C@@H](C(C)C)C(=O)NCC(C)(C)C(N)=O)C(C)C)=C1
198,lapatinib,NDA,2007,lapatinib,DB01259,approved; investigational,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC2=C(C=C1)N=CN=C2NC1=CC(Cl)=C(OCC2=CC(F)=CC=C2)C=C1
199,retapamulin,NDA,2007,retapamulin,DB01256,approved,[H][C@@]12C(=O)CC[C@]11CC[C@@H](C)[C@@]2(C)[C@@H](C[C@@](C)(C=C)[C@@H](O)[C@@H]1C)OC(=O)CS[C@H]1C[C@@H]2CC[C@H](C1)N2C
200,rotigotine,NDA,2007,rotigotine,DB05271,approved,CCCN(CCC1=CC=CS1)[C@H]1CCC2=C(O)C=CC=C2C1
201,temsirolimus,NDA,2007,temsirolimus,DB06287,approved,OCC(C)(CO)C(=O)O[C@@H]1CC[C@@H](C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@@H](OC)C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)C[C@H]1OC
202,ambrisentan,NDA,2007,ambrisentan,DB06403,approved; investigational,COC([C@H](OC1=NC(C)=CC(C)=N1)C(O)=O)(C1=CC=CC=C1)C1=CC=CC=C1
203,maraviroc,NDA,2007,maraviroc,DB04835,approved; investigational,CC(C)C1=NN=C(C)N1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)C1=CC=CC=C1
204,lanreotide,NDA,2007,lanreotide,DB06791,approved,[H]N([H])CCCCC1N([H])C(=O)C(CC2=CN([H])C3=CC=CC=C23)N([H])C(=O)C(CC2=CC=C(O)C=C2)N([H])C(=O)C(CSSCC(N([H])C(=O)C(N([H])C1=O)C(C)C)C(=O)N([H])C(C(C)O)C(=O)N([H])[H])N([H])C(=O)C(CC1=CC2=CC=CC=C2C=C1)N([H])[H]
205,doripenem,NDA,2007,doripenem,DB06211,approved; investigational,[H][C@]12[C@@H](C)C(S[C@@H]3CN[C@H](CNS(N)(=O)=O)C3)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O
206,raltegravir,NDA,2007,raltegravir,DB06817,approved,CN1C(=O)C(O)=C(N=C1C(C)(C)NC(=O)C1=NN=C(C)O1)C(=O)NCC1=CC=C(F)C=C1
207,ixabepilone,NDA,2007,ixabepilone,DB04845,approved; investigational,[H][C@]12C[C@H](NC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)CCC[C@@]1(C)O2)C(\C)=C\C1=CSC(C)=N1
208,nilotinib,NDA,2007,nilotinib,DB04868,approved; investigational,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F
209,sapropterin dihydrochloride,NDA,2007,sapropterin,DB00360,approved; investigational,[H][C@@]1(CNC2=C(N1)C(=O)NC(N)=N2)[C@@H](O)[C@H](C)O
210,nebivolol,NDA,2007,nebivolol,DB04861,approved; investigational,OC(CNCC(O)C1CCC2=C(O1)C=CC(F)=C2)C1CCC2=C(O1)C=CC(F)=C2
211,etravirine,NDA,2008,etravirine,DB06414,approved,CC1=CC(=CC(C)=C1OC1=C(Br)C(N)=NC(NC2=CC=C(C=C2)C#N)=N1)C#N
212,desvenlafaxine,NDA,2008,desvenlafaxine,DB06700,approved; investigational,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1
213,bendamustine hydrochloride,NDA,2008,bendamustine,DB06769,approved; investigational,CN1C(CCCC(O)=O)=NC2=CC(=CC=C12)N(CCCl)CCCl
214,regadenoson,NDA,2008,regadenoson,DB06213,approved; investigational,CNC(=O)C1=CN(N=C1)C1=NC2=C(N=CN2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(N)=N1
215,methylnaltrexoneÂ bromide,NDA,2008,methylnaltrexone,DB06800,approved,C[N@+]1(CC2CC2)CC[C@]23[C@H]4OC5=C(O)C=CC(C[C@@H]1[C@]2(O)CCC4=O)=C35
216,alvimopan,NDA,2008,alvimopan,DB06274,approved; investigational,C[C@H]1CN(C[C@H](CC2=CC=CC=C2)C(=O)NCC(O)=O)CC[C@@]1(C)C1=CC(O)=CC=C1
217,difluprednate,NDA,2008,difluprednate,DB06781,approved,[H][C@@]12CC[C@](OC(=O)CCC)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C
218,clevidipine,NDA,2008,clevidipine,DB04920,approved; investigational,CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(Cl)=C1Cl)C(=O)OC
219,tetrabenazine,NDA,2008,tetrabenazine,DB04844,approved; investigational,COC1=C(OC)C=C2C3CC(=O)C(CC(C)C)CN3CCC2=C1
220,silodosin,NDA,2008,silodosin,DB06207,approved,C[C@H](CC1=CC2=C(N(CCCO)CC2)C(=C1)C(N)=O)NCCOC1=CC=CC=C1OCC(F)(F)F
221,lacosamide,NDA,2008,lacosamide,DB06218,approved,COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1
222,fesoterodine fumarate,NDA,2008,fesoterodine,DB06702,approved,CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(OC(=O)C(C)C)C=CC(CO)=C1)C(C)C
223,rufinamide,NDA,2008,rufinamide,DB06201,approved,NC(=O)C1=CN(CC2=C(F)C=CC=C2F)N=N1
224,eltrombopag,NDA,2008,eltrombopag,DB06210,approved,CC1=NN(C(=O)\C1=N/NC1=CC=CC(C2=CC=CC(=C2)C(O)=O)=C1O)C1=CC=C(C)C(C)=C1
225,tapentadol,NDA,2008,tapentadol,DB06204,approved,CC[C@H]([C@@H](C)CN(C)C)C1=CC(O)=CC=C1
226,fospropofol disodium,NDA,2008,fospropofol,DB06716,approved; illicit; investigational,CC(C)C1=CC=CC(C(C)C)=C1OCOP(O)(O)=O
227,plerixafor,NDA,2008,plerixafor,DB06809,approved,C(N1CCCNCCNCCCNCC1)C1=CC=C(CN2CCCNCCNCCCNCC2)C=C1
228,degarelix,NDA,2008,degarelix,DB06699,approved,CC(C)C[C@H](NC(=O)[C@@H](CC1=CC=C(NC(N)=O)C=C1)NC(=O)[C@H](CC1=CC=C(NC(=O)[C@@H]2CC(=O)NC(=O)N2)C=C1)NC(=O)[C@H](CO)NC(=O)[C@@H](CC1=CC=CN=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC=C2C=CC=CC2=C1)NC(C)=O)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O
229,milnacipran hydrochloride,NDA,2009,milnacipran,DB04896,approved; investigational,CCN(CC)C(=O)C1(CC1CN)C1=CC=CC=C1
230,febuxostat,NDA,2009,febuxostat,DB04854,approved,CC(C)COC1=C(C=C(C=C1)C1=NC(C)=C(S1)C(O)=O)C#N
231,everolimus,NDA,2009,everolimus,DB01590,approved,[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)OC)CC[C@@H](OCCO)[C@@H](C1)OC
232,benzyl alcohol,NDA,2009,benzyl alcohol,DB06770,approved,OCC1=CC=CC=C1
233,iloperidone,NDA,2009,iloperidone,DB04946,approved,COC1=C(OCCCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C=CC(=C1)C(C)=O
234,tolvaptan,NDA,2009,tolvaptan,DB06212,approved,CC1=CC=CC=C1C(=O)NC1=CC(C)=C(C=C1)C(=O)N1CCC[C@@H](O)C2=C1C=CC(Cl)=C2
235,besifloxacin,NDA,2009,besifloxacin,DB06771,approved,N[C@@H]1CCCCN(C1)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=C1Cl)C(O)=O
236,dronedarone,NDA,2009,dronedarone,DB04855,approved,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2
237,prasugrel,NDA,2009,prasugrel,DB06209,approved,CC(=O)OC1=CC2=C(CCN(C2)C(C(=O)C2CC2)C2=CC=CC=C2F)S1
238,saxagliptin,NDA,2009,saxagliptin,DB06335,approved,[H][C@@]12C[C@]1([H])N([C@@H](C2)C#N)C(=O)[C@@H](N)C12CC3CC(CC(O)(C3)C1)C2
239,pitavastatin,NDA,2009,pitavastatin,DB08860,approved,O[C@H](C[C@H](O)\C=C\C1=C(N=C2C=CC=CC2=C1C1=CC=C(F)C=C1)C1CC1)CC(O)=O
240,asenapine,NDA,2009,asenapine,DB06216,approved,CN1CC2C(C1)C1=C(OC3=CC=C(Cl)C=C23)C=CC=C1
241,vigabatrin,NDA,2009,vigabatrin,DB01080,approved,NC(CCC(O)=O)C=C
242,bepotastine besilate,NDA,2009,bepotastine,DB04890,approved,OC(=O)CCCN1CCC(CC1)OC(C1=CC=C(Cl)C=C1)C1=CC=CC=N1
243,telavancin,NDA,2009,telavancin,DB06402,approved,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2OC2=C3OC4=CC=C(C=C4Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]4C(C=C2OC2=C(Cl)C=C(C=C2)[C@@H](O)[C@@H]2NC(=O)[C@H](NC4=O)C4=CC(=C(O)C=C4)C4=C(O)C(CNCP(O)(O)=O)=C(O)C=C4[C@H](NC2=O)C(O)=O)=C3)O[C@@H](C)[C@H]1O
244,pralatrexate,NDA,2009,pralatrexate,DB06813,approved; investigational,NC1=NC2=NC=C(CC(CC#C)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N=C2C(N)=N1
245,pazopanib,NDA,2009,pazopanib,DB06589,approved,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=CC=NC(NC2=CC=C(C)C(=C2)S(N)(=O)=O)=N1
246,romidepsin,NDA,2009,romidepsin,DB06176,approved; investigational,C\C=C1/NC(=O)[C@H]2CSSCC\C=C\[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@@H](NC1=O)C(C)C
247,capsaicin,NDA,2009,capsaicin,DB06774,approved,COC1=C(O)C=CC(CNC(=O)CCCC\C=C\C(C)C)=C1
248,dalfampridine,NDA,2010,dalfampridine,DB06637,approved,NC1=CC=NC=C1
249,carglumic acid,NDA,2010,carglumic acid,DB06775,approved,NC(=O)N[C@@H](CCC(O)=O)C(O)=O
250,polidocanol,NDA,2010,polidocanol,DB06811,approved,CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO
251,cabazitaxel,NDA,2010,cabazitaxel,DB06772,approved,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C4=CC=CC=C4)C(C)=C([C@@H](OC)C(=O)[C@]1(C)[C@H](C[C@H]1OC[C@@]21OC(C)=O)OC)C3(C)C
252,alcaftadine,NDA,2010,alcaftadine,DB06766,approved,CN1CCC(CC1)=C1C2=NC=C(C=O)N2CCC2=CC=CC=C12
253,ulipristal acetate,NDA,2010,ulipristal,DB08867,approved,CN(C)C1=CC=C(C=C1)[C@H]1C[C@@]2(C)[C@@H](CC[C@]2(O)C(C)=O)[C@@H]2CCC3=CC(=O)CCC3=C12
254,fingolimod,NDA,2010,fingolimod,DB08868,approved; investigational,CCCCCCCCC1=CC=C(CCC(N)(CO)CO)C=C1
255,dabigatran etexilate mesylate,NDA,2010,dabigatran etexilate,DB06695,approved,CCCCCCOC(=O)\N=C(\N)C1=CC=C(NCC2=NC3=C(C=CC(=C3)C(=O)N(CCC(=O)OCC)C3=NC=CC=C3)N2C)C=C1
256,lurasidone hydrochloride,NDA,2010,lurasidone,DB08815,approved; investigational,[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@H]1CN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O
257,ceftaroline fosamil,NDA,2010,ceftaroline fosamil,DB06590,approved; investigational,[H][C@]12SCC(SC3=NC(=CS3)C3=CC=[N+](C)C=C3)=C(N1C(=O)[C@H]2NC(=O)C(=N/OCC)\C1=NSC(NP(O)(O)=O)=N1)C([O-])=O
258,eribulin mesylate,NDA,2010,eribulin,DB08871,approved; investigational,[H][C@@]12CC(=C)[C@]([H])(CC[C@@]3([H])C[C@@H](C)C(=C)[C@@]([H])(C[C@]4([H])O[C@H](C[C@H](O)CN)[C@H](OC)[C@@]4([H])CC(=O)C[C@@]4([H])CC[C@]5([H])O[C@@]6([H])[C@H]7O[C@@]8(C[C@]7([H])O[C@@]6([H])[C@@]([H])(O8)[C@@]5([H])O4)CC1)O3)O2
259,spinosad,NDA,2011,spinosad,DB08823,approved; investigational; vet_approved,[H][C@]1(C[C@@]2([H])C=C[C@@]3([H])[C@]4([H])CC(=O)O[C@@]([H])(CC)CCC[C@]([H])(O[C@@]5([H])CC[C@]([H])(N(C)C)[C@@]([H])(C)O5)[C@@]([H])(C)C(=O)C4=C[C@@]3([H])[C@]2([H])C1)O[C@]1([H])O[C@@]([H])(C)[C@]([H])(OC)[C@@]([H])(OC)[C@@]1([H])OC.[H][C@]1(C[C@@]2([H])C(C)=C[C@@]3([H])[C@]4([H])CC(=O)O[C@@]([H])(CC)CCC[C@]([H])(O[C@@]5([H])CC[C@]([H])(N(C)C)[C@@]([H])(C)O5)[C@@]([H])(C)C(=O)C4=C[C@@]3([H])[C@]2([H])C1)O[C@]1([H])O[C@@]([H])(C)[C@]([H])(OC)[C@@]([H])(OC)[C@@]1([H])OC
260,vilazodone hydrochloride,NDA,2011,vilazodone,DB06684,approved,NC(=O)C1=CC2=CC(=CC=C2O1)N1CCN(CCCCC2=CNC3=C2C=C(C=C3)C#N)CC1
261,azilsartan medoxomil,NDA,2011,azilsartan medoxomil,DB08822,approved; investigational,CCOC1=NC2=C(N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NOC(=O)N1)C(=CC=C2)C(=O)OCC1=C(C)OC(=O)O1
262,roflumilast,NDA,2011,roflumilast,DB01656,approved,FC(F)OC1=C(OCC2CC2)C=C(C=C1)C(=O)NC1=C(Cl)C=NC=C1Cl
263,gadobutrol,NDA,2011,gadobutrol,DB06703,approved,OC[C@H](O)[C@H](CO)[N+]12CC[N+]3(CC([O-])=O)CC[N+]4(CC([O-])=O)CC[N+](CC([O-])=O)(CC1)[Gd-]234
264,gabapentin enacarbil,NDA,2011,gabapentin enacarbil,DB08872,approved; investigational,CC(C)C(=O)OC(C)OC(=O)NCC1(CC(O)=O)CCCCC1
265,abiraterone acetate,NDA,2011,abiraterone,DB05812,approved,[H][C@@]12CC=C(C3=CC=CN=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C
266,linagliptin,NDA,2011,linagliptin,DB08882,approved,CC#CCN1C(=NC2=C1C(=O)N(CC1=NC3=C(C=CC=C3)C(C)=N1)C(=O)N2C)N1CCC[C@@H](N)C1
267,boceprevir,NDA,2011,boceprevir,DB08873,approved; withdrawn,[H][C@]12CN([C@H](C(=O)NC(CC3CCC3)C(=O)C(N)=O)[C@@]1([H])C2(C)C)C(=O)[C@@H](NC(=O)NC(C)(C)C)C(C)(C)C
268,rilpivirine,NDA,2011,rilpivirine,DB08864,approved,CC1=CC(\C=C\C#N)=CC(C)=C1NC1=CC=NC(NC2=CC=C(C=C2)C#N)=N1
269,telaprevir,NDA,2011,telaprevir,DB05521,approved; withdrawn,[H][C@@]12CCC[C@]1([H])[C@H](N(C2)C(=O)[C@@H](NC(=O)[C@@H](NC(=O)C1=NC=CN=C1)C1CCCCC1)C(C)(C)C)C(=O)N[C@@H](CCC)C(=O)C(=O)NC1CC1
270,fidaxomicin,NDA,2011,fidaxomicin,DB08874,approved,[H][C@@]1(O[C@@H]2[C@@H](CC)\C=C(C)\[C@@H](O)C\C=C\C=C(CO[C@@H]3O[C@H](C)[C@@H](OC(=O)C4=C(CC)C(Cl)=C(O)C(Cl)=C4O)[C@H](O)[C@@H]3OC)\C(=O)O[C@@H](C\C=C(/C)\C=C2/C)[C@@H](C)O)OC(C)(C)[C@@H](OC(=O)C(C)C)[C@H](O)[C@@H]1O
271,ezogabine,NDA,2011,ezogabine,DB04953,approved; investigational,CCOC(=O)NC1=C(N)C=C(NCC2=CC=C(F)C=C2)C=C1
272,indacaterol,NDA,2011,indacaterol,DB05039,approved,CCC1=C(CC)C=C2CC(CC2=C1)NC[C@H](O)C1=C2C=CC(=O)NC2=C(O)C=C1
273,rivaroxaban,NDA,2011,rivaroxaban,DB06228,approved,ClC1=CC=C(S1)C(=O)NC[C@H]1CN(C(=O)O1)C1=CC=C(C=C1)N1CCOCC1=O
274,ticagrelor,NDA,2011,ticagrelor,DB08816,approved,CCCSC1=NC2=C(N=NN2[C@@H]2C[C@H](OCCO)[C@@H](O)[C@H]2O)C(N[C@@H]2C[C@H]2C2=CC(F)=C(F)C=C2)=N1
275,vemurafenib,NDA,2011,vemurafenib,DB08881,approved,CCCS(=O)(=O)NC1=C(F)C(C(=O)C2=CNC3=NC=C(C=C23)C2=CC=C(Cl)C=C2)=C(F)C=C1
276,icatibant,NDA,2011,icatibant,DB06196,approved; investigational,[H][C@]12C[C@]([H])(N(C(=O)[C@@]3([H])CC4=C(CN3C(=O)[C@H](CO)NC(=O)[C@H](CC3=CC=CS3)NC(=O)CNC(=O)[C@]3([H])C[C@@H](O)CN3C(=O)[C@@H]3CCCN3C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](N)CCCNC(N)=N)C=CC=C4)[C@@]1([H])CCCC2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O
277,crizotinib,NDA,2011,crizotinib,DB08865,approved,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl
278,deferiprone,NDA,2011,deferiprone,DB08826,approved,CN1C=CC(=O)C(O)=C1C
279,clobazam,NDA,2011,clobazam,DB00349,approved; illicit,CN1C2=C(C=C(Cl)C=C2)N(C2=CC=CC=C2)C(=O)CC1=O
280,ruxolitinib,NDA,2011,ruxolitinib,DB08877,approved,N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
281,ingenol mebutate,NDA,2012,ingenol mebutate,DB05013,approved,[H][C@@]12C[C@@H](C)[C@]34C=C(C)[C@H](OC(=O)C(\C)=C/C)[C@@]3(O)[C@H](O)C(CO)=C[C@@]([H])(C4=O)[C@]1([H])C2(C)C
282,axitinib,NDA,2012,axitinib,DB06626,approved; investigational,CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1
283,vismodegib,NDA,2012,vismodegib,DB08828,approved; investigational,CS(=O)(=O)C1=CC(Cl)=C(C=C1)C(=O)NC1=CC=C(Cl)C(=C1)C1=CC=CC=N1
284,ivacaftor,NDA,2012,ivacaftor,DB08820,approved,CC(C)(C)C1=CC(=C(O)C=C1NC(=O)C1=CNC2=CC=CC=C2C1=O)C(C)(C)C
285,tafluprost,NDA,2012,tafluprost,DB08819,approved,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\C(F)(F)COC1=CC=CC=C1
286,avanafil,NDA,2012,avanafil,DB06237,approved,COC1=C(Cl)C=C(CNC2=C(C=NC(=N2)N2CCC[C@H]2CO)C(=O)NCC2=NC=CC=N2)C=C1
287,lorcaserin hydrochloride,NDA,2012,lorcaserin,DB04871,approved,C[C@H]1CNCCC2=CC=C(Cl)C=C12
288,mirabegron,NDA,2012,mirabegron,DB08893,approved,NC1=NC(CC(=O)NC2=CC=C(CCNC[C@H](O)C3=CC=CC=C3)C=C2)=CS1
289,carfilzomib,NDA,2012,carfilzomib,DB08889,approved; investigational,CC(C)C[C@H](NC(=O)[C@H](CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1
290,aclidinium bromide,NDA,2012,aclidinium,DB08897,approved,OC(C(=O)O[C@H]1C[N+]2(CCCOC3=CC=CC=C3)CCC1CC2)(C1=CC=CS1)C1=CC=CS1
291,linaclotide,NDA,2012,linaclotide,DB08890,approved,[H][C@]1(CSSC[C@]2([H])NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]3CSSC[C@H](NC(=O)[C@H](C)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CSSC[C@H](N)C(=O)N3)NC2=O)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)NCC(=O)N1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O
292,enzalutamide,NDA,2012,enzalutamide,DB08899,approved,CNC(=O)C1=C(F)C=C(C=C1)N1C(=S)N(C(=O)C1(C)C)C1=CC=C(C#N)C(=C1)C(F)(F)F
293,bosutinib,NDA,2012,bosutinib,DB06616,approved,COC1=CC(NC2=C(C=NC3=CC(OCCCN4CCN(C)CC4)=C(OC)C=C23)C#N)=C(Cl)C=C1Cl
294,teriflunomide,NDA,2012,teriflunomide,DB08880,approved,C\C(O)=C(/C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F
295,regorafenib,NDA,2012,regorafenib,DB08896,approved,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
296,perampanel,NDA,2012,perampanel,DB08883,approved,O=C1N(C=C(C=C1C1=CC=CC=C1C#N)C1=NC=CC=C1)C1=CC=CC=C1
297,tofacitinib,NDA,2012,tofacitinib,DB08895,approved; investigational,C[C@@H]1CCN(C[C@@H]1N(C)C1=NC=NC2=C1C=CN2)C(=O)CC#N
298,cabozantinib,NDA,2012,cabozantinib,DB08875,approved; investigational,COC1=CC2=C(C=C1OC)C(OC1=CC=C(NC(=O)C3(CC3)C(=O)NC3=CC=C(F)C=C3)C=C1)=CC=N2
299,pasireotide,NDA,2012,pasireotide,DB06663,approved,NCCCC[C@@H]1NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@@H](NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(OCC3=CC=CC=C3)C=C2)NC1=O)OC(=O)NCCN)C1=CC=CC=C1
300,ponatinib,NDA,2012,ponatinib,DB08901,approved; investigational,CN1CCN(CC2=CC=C(NC(=O)C3=CC(C#CC4=CN=C5C=CC=NN45)=C(C)C=C3)C=C2C(F)(F)F)CC1
301,lomitapide,NDA,2012,lomitapide,DB08827,approved; investigational,FC(F)(F)CNC(=O)C1(CCCCN2CCC(CC2)NC(=O)C2=C(C=CC=C2)C2=CC=C(C=C2)C(F)(F)F)C2=CC=CC=C2C2=CC=CC=C12
302,apixaban,NDA,2012,apixaban,DB06605,approved,COC1=CC=C(C=C1)N1N=C(C(N)=O)C2=C1C(=O)N(CC2)C1=CC=C(C=C1)N1CCCCC1=O
303,bedaquiline,NDA,2012,bedaquiline,DB08903,approved,COC1=NC2=C(C=C(Br)C=C2)C=C1[C@@H](C1=CC=CC=C1)[C@@](O)(CCN(C)C)C1=CC=CC2=C1C=CC=C2
304,alogliptin,NDA,2013,alogliptin,DB06203,approved,CN1C(=O)C=C(N2CCC[C@@H](N)C2)N(CC2=C(C=CC=C2)C#N)C1=O
305,mipomersen sodium,NDA,2013,mipomersen,DB05528,approved; investigational,COCCO[C@H]1[C@@H](O)[C@H](COP(O)(=O)S[C@H]2[C@H](COP(O)(=O)S[C@H]3[C@H](COP(O)(=O)S[C@H]4[C@H](COP(O)(=O)S[C@@H]5[C@@H](COP(O)(=O)S[C@H]6C[C@@H](O[C@@H]6COP(O)(=O)S[C@H]6C[C@@H](O[C@@H]6COP(O)(=O)S[C@H]6C[C@@H](O[C@@H]6COP(O)(=O)S[C@H]6C[C@@H](O[C@@H]6COP(O)(=O)S[C@H]6C[C@@H](O[C@@H]6COP(O)(=O)S[C@H]6C[C@@H](O[C@@H]6COP(O)(=O)S[C@H]6C[C@@H](O[C@@H]6COP(O)(=O)S[C@H]6C[C@@H](O[C@@H]6COP(O)(=O)S[C@H]6C[C@@H](O[C@@H]6COP(O)(=O)S[C@H]6C[C@@H](O[C@@H]6COP(O)(=O)S[C@@H]6[C@@H](COP(O)(=O)S[C@@H]7[C@@H](COP(O)(=O)S[C@@H]8[C@@H](COP(O)(=O)S[C@@H]9[C@@H](COP(O)(=O)S[C@@H]%10[C@@H](CO)O[C@H]([C@@H]%10OCCOC)N%10C=NC%11=C%10N=C(N)NC%11=O)O[C@H]([C@@H]9OCCOC)N9C=C(C)C(N)=NC9=O)O[C@H]([C@@H]8OCCOC)N8C=C(C)C(N)=NC8=O)O[C@H]([C@@H]7OCCOC)N7C=C(C)C(=O)NC7=O)O[C@H]([C@@H]6OCCOC)N6C=C(C)C(N)=NC6=O)N6C=NC7=C6N=CN=C7N)N6C=NC7=C6N=C(N)NC7=O)N6C=C(C)C(=O)NC6=O)N6C=C(C)C(N)=NC6=O)N6C=C(C)C(=O)NC6=O)N6C=NC7=C6N=C(N)NC7=O)N6C=C(C)C(N)=NC6=O)N6C=C(C)C(=O)NC6=O)N6C=C(C)C(=O)NC6=O)N6C=C(C)C(N)=NC6=O)O[C@H]([C@@H]5OCCOC)N5C=NC6=C5N=C(N)NC6=O)O[C@@H]([C@H]4OCCOC)N4C=C(C)C(N)=NC4=O)O[C@@H]([C@H]3OCCOC)N3C=NC4=C3N=CN=C4N)O[C@@H]([C@H]2OCCOC)N2C=C(C)C(N)=NC2=O)O[C@@H]1N1C=C(C)C(N)=NC1=O
306,pomalidomide,NDA,2013,pomalidomide,DB08910,approved,NC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O
307,ospemifene,NDA,2013,ospemifene,DB04938,approved; investigational,OCCOC1=CC=C(C=C1)C(=C(\CCCl)C1=CC=CC=C1)\C1=CC=CC=C1
308,canagliflozin,NDA,2013,canagliflozin,DB08907,approved,[H][C@]1(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C1=CC=C(C)C(CC2=CC=C(S2)C2=CC=C(F)C=C2)=C1
309,dabrafenib,NDA,2013,dabrafenib,DB08912,approved; investigational,CC(C)(C)C1=NC(=C(S1)C1=NC(N)=NC=C1)C1=C(F)C(NS(=O)(=O)C2=C(F)C=CC=C2F)=CC=C1
310,trametinib,NDA,2013,trametinib,DB08911,approved,CN1C(=O)C(C)=C2N(C(=O)N(C3CC3)C(=O)C2=C1NC1=CC=C(I)C=C1F)C1=CC(NC(C)=O)=CC=C1
311,afatinib,NDA,2013,afatinib,DB08916,approved,CN(C)C\C=C\C(=O)NC1=C(O[C@H]2CCOC2)C=C2N=CN=C(NC3=CC(Cl)=C(F)C=C3)C2=C1
312,dolutegravir,NDA,2013,dolutegravir,DB08930,approved,[H][C@]12CN3C=C(C(=O)NCC4=CC=C(F)C=C4F)C(=O)C(O)=C3C(=O)N1[C@H](C)CCO2
313,vortioxetine,NDA,2013,vortioxetine,DB09068,approved; investigational,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1
314,riociguat,NDA,2013,riociguat,DB08931,approved,COC(=O)N(C)C1=C(N)N=C(N=C1N)C1=NN(CC2=C(F)C=CC=C2)C2=C1C=CC=N2
315,macitentan,NDA,2013,macitentan,DB08932,approved,CCCNS(=O)(=O)NC1=C(C(OCCOC2=NC=C(Br)C=N2)=NC=N1)C1=CC=C(Br)C=C1
316,eslicarbazepine acetate,NDA,2013,eslicarbazepine,DB14575,approved,NC(=O)N1C2=C(C[C@H](O)C3=C1C=CC=C3)C=CC=C2
317,ibrutinib,NDA,2013,ibrutinib,DB09053,approved,NC1=NC=NC2=C1C(=NN2[C@@H]1CCCN(C1)C(=O)C=C)C1=CC=C(OC2=CC=CC=C2)C=C1
318,luliconazole,NDA,2013,luliconazole,DB08933,approved,ClC1=CC(Cl)=C(C=C1)[C@@H]1CS\C(S1)=C(\C#N)N1C=CN=C1
319,simeprevir,NDA,2013,simeprevir,DB06290,approved,[H][C@]12C[C@]1(NC(=O)[C@]1([H])C[C@H](C[C@@]1([H])C(=O)N(C)CCCC\C=C/2)OC1=CC(=NC2=C1C=CC(OC)=C2C)C1=NC(=CS1)C(C)C)C(=O)NS(=O)(=O)C1CC1
320,sofosbuvir,NDA,2013,sofosbuvir,DB08934,approved,CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](N2C=CC(=O)NC2=O)[C@](C)(F)[C@@H]1O)OC1=CC=CC=C1
321,dapagliflozin,NDA,2014,dapagliflozin,DB06292,approved,CCOC1=CC=C(CC2=C(Cl)C=CC(=C2)[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C1
322,tasimelteon,NDA,2014,tasimelteon,DB09071,approved; investigational,CCC(=O)NC[C@@H]1C[C@H]1C1=CC=CC2=C1CCO2
323,droxidopa,NDA,2014,droxidopa,DB06262,approved; investigational,N[C@@H]([C@H](O)C1=CC(O)=C(O)C=C1)C(O)=O
324,miltefosine,NDA,2014,miltefosine,DB09031,approved; investigational,CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C
325,apremilast,NDA,2014,apremilast,DB05676,approved; investigational,CCOC1=CC(=CC=C1OC)[C@@H](CS(C)(=O)=O)N1C(=O)C2=CC=CC(NC(C)=O)=C2C1=O
326,ceritinib,NDA,2014,ceritinib,DB09063,approved,CC(C)OC1=C(NC2=NC=C(Cl)C(N2)=NC2=CC=CC=C2S(=O)(=O)C(C)C)C=C(C)C(=C1)C1CCNCC1
327,vorapaxar,NDA,2014,vorapaxar,DB09030,approved,[H][C@@]12C[C@]3([H])C[C@@H](CC[C@@]3([H])[C@H](\C=C\C3=CC=C(C=N3)C3=CC(F)=CC=C3)[C@]1([H])[C@@H](C)OC2=O)NC(=O)OCC
328,efinaconazole,NDA,2014,efinaconazole,DB09040,approved,C[C@@H](N1CCC(=C)CC1)[C@](O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1
329,tedizolid phosphate,NDA,2014,tedizolid,DB14569,approved; investigational,CN1N=NC(=N1)C1=NC=C(C=C1)C1=C(F)C=C(C=C1)N1C[C@H](CO)OC1=O
330,belinostat,NDA,2014,belinostat,DB05015,approved; investigational,ONC(=O)\C=C\C1=CC=CC(=C1)S(=O)(=O)NC1=CC=CC=C1
331,tavaborole,NDA,2014,tavaborole,DB09041,approved; investigational,OB1OCC2=CC(F)=CC=C12
332,idelalisib,NDA,2014,idelalisib,DB09054,approved,[H][C@@](CC)(NC1=NC=NC2=C1N=CN2)C1=NC2=CC=CC(F)=C2C(=O)N1C1=CC=CC=C1
333,olodaterol,NDA,2014,olodaterol,DB09080,approved,COC1=CC=C(CC(C)(C)NC[C@H](O)C2=C3OCC(=O)NC3=CC(O)=C2)C=C1
334,empagliflozin,NDA,2014,empagliflozin,DB09038,approved,OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C1=CC=C(Cl)C(CC2=CC=C(O[C@H]3CCOC3)C=C2)=C1
335,oritavancin diphosphate,NDA,2014,oritavancin,DB04911,approved; investigational,CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@](C)(NCC5=CC=C(C=C5)C5=CC=C(Cl)C=C5)[C@@H](O)[C@H](C)O4)C4=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H]1C3=CC(=C(O)C=C3)C3=C(O)C=C(O)C=C3[C@H](NC(=O)[C@@H](NC1=O)[C@H](O[C@H]1C[C@](C)(N)[C@@H](O)[C@H](C)O1)C1=CC(Cl)=C(O4)C=C1)C(O)=O)C(Cl)=C2
336,suvorexant,NDA,2014,suvorexant,DB09034,approved; investigational,[H][C@@]1(C)CCN(CCN1C(=O)C1=C(C=CC(C)=C1)N1N=CC=N1)C1=NC2=C(O1)C=CC(Cl)=C2
337,eliglustat,NDA,2014,eliglustat,DB09039,approved,CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@H](O)C1=CC=C2OCCOC2=C1
338,naloxegol,NDA,2014,naloxegol,DB09049,approved,COCCOCCOCCOCCOCCOCCOCCO[C@H]1CC[C@@]2(O)[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3CC=C)[C@H]1O5
339,pirfenidone,NDA,2014,pirfenidone,DB04951,approved; investigational,CC1=CN(C(=O)C=C1)C1=CC=CC=C1
340,nintedanib,NDA,2014,nintedanib,DB09079,approved,COC(=O)C1=CC=C2C(NC(=O)\C2=C(/NC2=CC=C(C=C2)N(C)C(=O)CN2CCN(C)CC2)C2=CC=CC=C2)=C1
341,finafloxacin,NDA,2014,finafloxacin,DB09047,approved; investigational,[H][C@]12CN(C[C@]1([H])OCCN2)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=C1C#N)C(O)=O
342,olaparib,NDA,2014,olaparib,DB09074,approved,FC1=CC=C(CC2=NNC(=O)C3=CC=CC=C23)C=C1C(=O)N1CCN(CC1)C(=O)C1CC1
343,peramivir,NDA,2014,peramivir,DB06614,approved; investigational,[H][C@@]1([C@@H](NC(C)=O)C(CC)CC)[C@H](O)[C@H](C[C@H]1NC(N)=N)C(O)=O
344,edoxaban tosylate,NDA,2015,edoxaban,DB09075,approved,CN(C)C(=O)[C@H]1CC[C@H](NC(=O)C(=O)NC2=NC=C(Cl)C=C2)[C@@H](C1)NC(=O)C1=NC2=C(CN(C)CC2)S1
345,palbociclib,NDA,2015,palbociclib,DB09073,approved; investigational,CC(=O)C1=C(C)C2=CN=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2N(C2CCCC2)C1=O
346,lenvatinib,NDA,2015,lenvatinib,DB09078,approved; investigational,COC1=C(C=C2C(OC3=CC=C(NC(=O)NC4CC4)C(Cl)=C3)=CC=NC2=C1)C(N)=O
347,panobinostat,NDA,2015,panobinostat,DB06603,approved; investigational,CC1=C(CCNCC2=CC=C(\C=C\C(=O)NO)C=C2)C2=CC=CC=C2N1
348,isavuconazonium sulfate,NDA,2015,isavuconazonium,DB06636,approved; investigational,[H]C(C)(OC(=O)N(C)C1=C(COC(=O)CNC)C=CC=N1)[N+]1=CN(C[C@](O)(C2=C(F)C=CC(F)=C2)[C@@]([H])(C)C2=NC(=CS2)C2=CC=C(C=C2)C#N)N=C1
349,cholic acid,NDA,2015,cholic acid,DB02659,approved,[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@]([H])(O)C[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])C[C@]([H])(O)[C@]12C
350,ivabradine,NDA,2015,ivabradine,DB09083,approved,COC1=C(OC)C=C2[C@@H](CN(C)CCCN3CCC4=CC(OC)=C(OC)C=C4CC3=O)CC2=C1
351,deoxycholic acid,NDA,2015,deoxycholic acid,DB03619,approved,[H][C@@]12CC[C@H]([C@H](C)CCC(O)=O)[C@@]1(C)[C@@H](O)C[C@@]1([H])[C@@]2([H])CC[C@]2([H])C[C@H](O)CC[C@]12C
352,eluxadoline,NDA,2015,eluxadoline,DB09272,approved; investigational,COC1=CC=C(CN([C@@H](C)C2=NC(=CN2)C2=CC=CC=C2)C(=O)[C@@H](N)CC2=C(C)C=C(C=C2C)C(N)=O)C=C1C(O)=O
353,cangrelor,NDA,2015,cangrelor,DB06441,approved,CSCCNC1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)C(Cl)(Cl)P(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC(SCCC(F)(F)F)=N1
354,brexpiprazole,NDA,2015,brexpiprazole,DB09128,approved; investigational,O=C1NC2=CC(OCCCCN3CCN(CC3)C3=C4C=CSC4=CC=C3)=CC=C2C=C1
355,sonidegib,NDA,2015,sonidegib,DB09143,approved; investigational,[H][C@]1(C)CN(C[C@@]([H])(C)O1)C1=CC=C(NC(=O)C2=CC=CC(=C2C)C2=CC=C(OC(F)(F)F)C=C2)C=N1
356,daclatasvir,NDA,2015,daclatasvir,DB09102,approved; investigational,COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C1=NC=C(N1)C1=CC=C(C=C1)C1=CC=C(C=C1)C1=CN=C(N1)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)OC)C(C)C
357,flibanserin,NDA,2015,flibanserin,DB04908,approved; investigational,FC(F)(F)C1=CC(=CC=C1)N1CCN(CCN2C(=O)NC3=CC=CC=C23)CC1
358,rolapitant,NDA,2015,rolapitant,DB09291,approved; investigational,C[C@@H](OC[C@]1(CC[C@]2(CCC(=O)N2)CN1)C1=CC=CC=C1)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F
359,uridine triacetate,NDA,2015,uridine triacetate,DB09144,approved; investigational,CC(=O)OC[C@H]1O[C@H]([C@H](OC(C)=O)[C@@H]1OC(C)=O)N1C=CC(=O)NC1=O
360,cariprazine,NDA,2015,cariprazine,DB06016,approved; investigational,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)C2=C(Cl)C(Cl)=CC=C2)CC1
361,aripiprazole lauroxil,NDA,2015,aripiprazole lauroxil,DB14185,approved; investigational,CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12
362,trabectedin,NDA,2015,trabectedin,DB05109,approved; investigational,[H][C@@]12[C@@H]3SC[C@]4(NCCC5=C4C=C(OC)C(O)=C5)C(=O)OC[C@H](N1[C@@H](O)[C@@H]1CC4=CC(C)=C(OC)C(O)=C4[C@H]2N1C)C1=C2OCOC2=C(C)C(OC(C)=O)=C31
363,cobimetinib,NDA,2015,cobimetinib,DB05239,approved; investigational,OC1(CN(C1)C(=O)C1=C(NC2=C(F)C=C(I)C=C2)C(F)=C(F)C=C1)[C@@H]1CCCCN1
364,osimertinib,NDA,2015,osimertinib,DB09330,approved,COC1=C(NC2=NC=CC(=N2)C2=CN(C)C3=C2C=CC=C3)C=C(NC(=O)C=C)C(=C1)N(C)CCN(C)C
365,ixazomib,NDA,2015,ixazomib,DB09570,approved; investigational,CC(C)C[C@H](NC(=O)CNC(=O)C1=CC(Cl)=CC=C1Cl)B(O)O
366,alectinib,NDA,2015,alectinib,DB11363,approved; investigational,CCC1=CC2=C(C=C1N1CCC(CC1)N1CCOCC1)C(C)(C)C1=C(C3=CC=C(C=C3N1)C#N)C2=O
367,sugammadex,NDA,2015,sugammadex,DB06206,approved,O[C@@H]1[C@@H](O)[C@@H]2O[C@H]3O[C@H](CSCCC(O)=O)[C@@H](O[C@H]4O[C@H](CSCCC(O)=O)[C@@H](O[C@H]5O[C@H](CSCCC(O)=O)[C@@H](O[C@H]6O[C@H](CSCCC(O)=O)[C@@H](O[C@H]7O[C@H](CSCCC(O)=O)[C@@H](O[C@H]8O[C@H](CSCCC(O)=O)[C@@H](O[C@H]9O[C@H](CSCCC(O)=O)[C@@H](O[C@H]1O[C@@H]2CSCCC(O)=O)[C@H](O)[C@H]9O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O
368,selexipag,NDA,2015,selexipag,DB11362,approved,CC(C)N(CCCCOCC(=O)NS(C)(=O)=O)C1=NC(C2=CC=CC=C2)=C(N=C1)C1=CC=CC=C1
369,lesinurad,NDA,2015,lesinurad,DB11560,approved; investigational,OC(=O)CSC1=NN=C(Br)N1C1=CC=C(C2CC2)C2=C1C=CC=C2
370,brivaracetam,NDA,2016,brivaracetam,DB05541,approved; investigational,CCC[C@H]1CN([C@@H](CC)C(N)=O)C(=O)C1
371,venetoclax,NDA,2016,venetoclax,DB11581,approved; investigational,CC1(C)CCC(CN2CCN(CC2)C2=CC=C(C(=O)NS(=O)(=O)C3=CC=C(NCC4CCOCC4)C(=C3)[N+]([O-])=O)C(OC3=CN=C4NC=CC4=C3)=C2)=C(C1)C1=CC=C(Cl)C=C1
372,pimavanserin,NDA,2016,pimavanserin,DB05316,approved; investigational,CC(C)COC1=CC=C(CNC(=O)N(CC2=CC=C(F)C=C2)C2CCN(C)CC2)C=C1
373,obeticholic acid,NDA,2016,obeticholic acid,DB05990,approved,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)[C@H](CC)[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O
374,lifitegrast,NDA,2016,lifitegrast,DB11611,approved,CS(=O)(=O)C1=CC(C[C@H](NC(=O)C2=C(Cl)C3=C(CN(CC3)C(=O)C3=CC=C4C=COC4=C3)C=C2Cl)C(O)=O)=CC=C1
375,crisaborole,NDA,2016,crisaborole,DB05219,approved; investigational,OB1OCC2=C1C=CC(OC1=CC=C(C=C1)C#N)=C2
376,rucaparib,NDA,2016,rucaparib,DB12332,approved; investigational,CNCC1=CC=C(C=C1)C1=C2CCNC(=O)C3=C2C(N1)=CC(F)=C3
377,plecanatide,NDA,2017,plecanatide,DB13170,approved; investigational,[H][C@@]12CSSC[C@H](NC(=O)CNC(=O)[C@@]([H])(NC(=O)[C@]([H])(CSSC[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC2=O)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O
378,etelcalcetide,NDA,2017,etelcalcetide,DB12865,approved; investigational,C[C@@H](NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](C)NC(=O)[C@@H](CSSC[C@H](N)C(O)=O)NC(C)=O)C(=O)N[C@H](CCCNC(N)=N)C(N)=O
379,deflazacort,NDA,2017,deflazacort,DB11921,approved; investigational,[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@]([H])(O)C[C@]3(C)[C@@]1(N=C(C)O2)C(=O)COC(C)=O
380,telotristat ethyl,NDA,2017,telotristat ethyl,DB12095,approved; investigational,CCOC(=O)[C@@H](N)CC1=CC=C(C=C1)C1=NC(N)=NC(O[C@H](C2=CC=C(Cl)C=C2N2C=CC(C)=N2)C(F)(F)F)=C1
381,ribociclib,NDA,2017,ribociclib,DB11730,approved; investigational,CN(C)C(=O)C1=CC2=CN=C(NC3=CC=C(C=N3)N3CCNCC3)N=C2N1C1CCCC1
382,safinamide,NDA,2017,safinamide,DB06654,approved; investigational,C[C@H](NCC1=CC=C(OCC2=CC(F)=CC=C2)C=C1)C(N)=O
383,naldemedine,NDA,2017,naldemedine,DB11691,approved; investigational,[H][C@@]12OC3=C4C(C[C@@]5([H])N(CC6CC6)CC[C@@]14[C@@]5(O)CC(C(=O)NC(C)(C)C1=NC(=NO1)C1=CC=CC=C1)=C2O)=CC=C3O
384,niraparib,NDA,2017,niraparib,DB11793,approved; investigational,NC(=O)C1=CC=CC2=CN(N=C12)C1=CC=C(C=C1)[C@@H]1CCCNC1
385,deutetrabenazine,NDA,2017,deutetrabenazine,DB12161,approved; investigational,[2H]C([2H])([2H])OC1=CC2=C(C=C1OC([2H])([2H])[2H])[C@@H]1CC(=O)[C@@H](CC(C)C)CN1CC2
386,valbenazine,NDA,2017,valbenazine,DB11915,approved; investigational,COC1=C(OC)C=C2[C@H]3C[C@@H](OC(=O)[C@@H](N)C(C)C)[C@H](CC(C)C)CN3CCC2=C1
387,midostaurin,NDA,2017,midostaurin,DB06595,approved; investigational,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O)N(C)C(=O)C1=CC=CC=C1
388,brigatinib,NDA,2017,brigatinib,DB12267,approved; investigational,COC1=CC(=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2P(C)(C)=O)=N1)N1CCC(CC1)N1CCN(C)CC1
389,edaravone,NDA,2017,edaravone,DB12243,approved; investigational,CC1=NN(C(=O)C1)C1=CC=CC=C1
390,delafloxacin,NDA,2017,delafloxacin,DB11943,approved; investigational,NC1=NC(N2C=C(C(O)=O)C(=O)C3=CC(F)=C(N4CC(O)C4)C(Cl)=C23)=C(F)C=C1F
391,betrixaban,NDA,2017,betrixaban,DB12364,approved; investigational,COC1=CC=C(NC(=O)C2=CC=C(C=C2)C(=N)N(C)C)C(=C1)C(=O)NC1=CC=C(Cl)C=N1
392,neratinib,NDA,2017,neratinib,DB11828,approved; investigational,CCOC1=C(NC(=O)\C=C\CN(C)C)C=C2C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C(C=NC2=C1)C#N
393,enasidenib,NDA,2017,enasidenib,DB13874,approved; investigational,CC(C)(O)CNC1=NC(=NC(NC2=CC(=NC=C2)C(F)(F)F)=N1)C1=NC(=CC=C1)C(F)(F)F
394,benznidazole,NDA,2017,benznidazole,DB11989,approved; investigational,[O-][N+](=O)C1=NC=CN1CC(=O)NCC1=CC=CC=C1
395,copanlisib,NDA,2017,copanlisib,DB12483,approved; investigational,COC1=C(OCCCN2CCOCC2)C=CC2=C1N=C(NC(=O)C1=CN=C(N)N=C1)N1CCN=C21
396,secnidazole,NDA,2017,secnidazole,DB12834,approved,CC(O)CN1C(C)=NC=C1N(=O)=O
397,abemaciclib,NDA,2017,abemaciclib,DB12001,approved; investigational,CCN1CCN(CC2=CC=C(NC3=NC=C(F)C(=N3)C3=CC(F)=C4N=C(C)N(C(C)C)C4=C3)N=C2)CC1
398,acalabrutinib,NDA,2017,acalabrutinib,DB11703,approved; investigational,CC#CC(=O)N1CCC[C@H]1C1=NC(=C2N1C=CN=C2N)C1=CC=C(C=C1)C(=O)NC1=CC=CC=N1
399,latanoprostene bunod,NDA,2017,latanoprostene bunod,DB11660,approved; investigational,O[C@H](CC[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(=O)OCCCCO[N+]([O-])=O)CCC1=CC=CC=C1
400,letermovir,NDA,2017,letermovir,DB12070,approved; investigational,COC1=CC=CC(=C1)N1CCN(CC1)C1=NC2=C(C=CC=C2F)[C@H](CC(O)=O)N1C1=CC(=CC=C1OC)C(F)(F)F
401,semaglutide,NDA,2017,semaglutide,DB13928,approved; investigational,CC[C@H](C)[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)C(C)(C)NC(=O)[C@@H](N)CC1=CN=CN1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O
402,ozenoxacin,NDA,2017,ozenoxacin,DB12924,approved; investigational,CNC1=NC=C(C=C1C)C1=CC=C2C(=O)C(=CN(C3CC3)C2=C1C)C(O)=O
403,netarsudil,NDA,2017,netarsudil,DB13931,approved,CC1=CC(C)=C(C=C1)C(=O)OCC1=CC=C(C=C1)[C@@H](CN)C(=O)NC1=CC=C2C=NC=CC2=C1
404,ertugliflozin,NDA,2017,ertugliflozin,DB11827,approved; investigational,CCOC1=CC=C(CC2=CC(=CC=C2Cl)[C@]23OC[C@](CO)(O2)[C@@H](O)[C@H](O)[C@H]3O)C=C1
405,macimorelin,NDA,2017,macimorelin,DB13074,approved; investigational,CC(C)(N)C(=O)N[C@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@H](CC1=CNC2=CC=CC=C12)NC=O
406,apalutamide,NDA,2018,apalutamide,DB11901,approved; investigational,CNC(=O)C1=CC=C(C=C1F)N1C(=S)N(C(=O)C11CCC1)C1=CC(=C(N=C1)C#N)C(F)(F)F
407,fostamatinib disodium hexahydrate,NDA,2018,fostamatinib,DB12010,approved; investigational,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
408,lofexidine,NDA,2018,lofexidine,DB04948,approved; investigational,CC(OC1=C(Cl)C=CC=C1Cl)C1=NCCN1
409,avatrombopag,NDA,2018,avatrombopag,DB11995,approved; investigational,OC(=O)C1CCN(CC1)C1=C(Cl)C=C(C=N1)C(=O)NC1=NC(C2=CC(Cl)=CS2)=C(S1)N1CCN(CC1)C1CCCCC1
410,baricitinib,NDA,2018,baricitinib,DB11817,approved; investigational,CCS(=O)(=O)N1CC(CC#N)(C1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1
411,moxidectin,NDA,2018,moxidectin,DB11431,approved; investigational; vet_approved,[H][C@@]12OC\C3=C/C=C/[C@H](C)C\C(C)=C\C[C@]4([H])C[C@@]([H])(C[C@]5(C\C(=N/OC)[C@H](C)[C@H](O5)C(\C)=C\C(C)C)O4)OC(=O)[C@]([H])(C=C(C)[C@H]1O)[C@@]23O
412,plazomicin,NDA,2018,plazomicin,DB12615,approved; investigational,CN[C@@H]1[C@@H](O)[C@@H](O[C@H]2[C@@H](C[C@H](N)[C@@H](O[C@H]3OC(CNCCO)=CC[C@H]3N)[C@@H]2O)NC(=O)[C@@H](O)CCN)OC[C@]1(C)O
413,cannabidiol,NDA,2018,cannabidiol,DB09061,approved; investigational,CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1
414,encorafenib,NDA,2018,encorafenib,DB11718,approved; investigational,COC(=O)N[C@@H](C)CNC1=NC=CC(=N1)C1=CN(N=C1C1=CC(Cl)=CC(NS(C)(=O)=O)=C1F)C(C)C
415,binimetinib,NDA,2018,binimetinib,DB11967,approved; investigational,CN1C=NC2=C(F)C(NC3=CC=C(Br)C=C3F)=C(C=C12)C(=O)NOCCO
416,tecovirimat,NDA,2018,tecovirimat,DB12020,approved; investigational,FC(F)(F)C1=CC=C(C=C1)C(=O)NN1C(=O)[C@H]2[C@H]([C@H]3C=C[C@@H]2[C@@H]2C[C@H]32)C1=O
417,tafenoquine,NDA,2018,tafenoquine,DB06608,approved; investigational,COC1=CC(C)=C2C(OC3=CC=CC(=C3)C(F)(F)F)=C(OC)C=C(NC(C)CCCN)C2=N1
418,ivosidenib,NDA,2018,ivosidenib,DB14568,approved; investigational,[H][C@@](N(C(=O)[C@]1([H])CCC(=O)N1C1=NC=CC(=C1)C#N)C1=CC(F)=CN=C1)(C(=O)NC1CC(F)(F)C1)C1=C(Cl)C=CC=C1
419,elagolix,NDA,2018,elagolix,DB11979,approved; investigational,COC1=CC=CC(=C1F)C1=C(C)N(CC2=C(C=CC=C2F)C(F)(F)F)C(=O)N(C[C@H](NCCCC(O)=O)C2=CC=CC=C2)C1=O
420,lusutrombopag,NDA,2018,lusutrombopag,DB13125,approved; investigational,CCCCCCO[C@@H](C)C1=C(OC)C(=CC=C1)C1=CSC(NC(=O)C2=CC(Cl)=C(\C=C(/C)C(O)=O)C(Cl)=C2)=N1
421,migalastat,NDA,2018,migalastat,DB05018,approved; investigational,OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O
422,stiripentol,NDA,2018,stiripentol,DB09118,approved,CC(C)(C)C(O)\C=C\C1=CC2=C(OCO2)C=C1
423,eravacycline,NDA,2018,eravacycline,DB12329,approved; investigational,[H][C@@]12CC3=C(F)C=C(NC(=O)CN4CCCC4)C(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2
424,doravirine,NDA,2018,doravirine,DB12301,approved; investigational,CN1C(=O)NN=C1CN1C=CC(=C(OC2=CC(=CC(Cl)=C2)C#N)C1=O)C(F)(F)F
425,duvelisib,NDA,2018,duvelisib,DB11952,approved; investigational,C[C@H](NC1=C2N=CNC2=NC=N1)C1=CC2=CC=CC(Cl)=C2C(=O)N1C1=CC=CC=C1
426,dacomitinib,NDA,2018,dacomitinib,DB11963,approved; investigational,COC1=C(NC(=O)\C=C\CN2CCCCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1
427,sarecycline,NDA,2018,sarecycline,DB12035,approved; investigational,[H][C@@]12CC3=C(CN(C)OC)C=CC(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2
428,omadacycline,NDA,2018,omadacycline,DB12455,approved; investigational,[H][C@@]12CC3=C(C=C(CNCC(C)(C)C)C(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2)N(C)C
429,talazoparib,NDA,2018,talazoparib,DB11760,approved; investigational,CN1N=CN=C1[C@@H]1[C@H](NC2=C3C1=NNC(=O)C3=CC(F)=C2)C1=CC=C(F)C=C1
430,baloxavir marboxil,NDA,2018,baloxavir marboxil,DB13997,approved; investigational,[H][C@@]12COCCN1C(=O)C1=C(OCOC(=O)OC)C(=O)C=CN1N2[C@H]1C2=CC=C(F)C(F)=C2CSC2=CC=CC=C12
431,lorlatinib,NDA,2018,lorlatinib,DB12130,approved; investigational,C[C@H]1OC2=C(N)N=CC(=C2)C2=C(C#N)N(C)N=C2CN(C)C(=O)C2=C1C=C(F)C=C2
432,revefenacin,NDA,2018,revefenacin,DB11855,approved; investigational,CN(CCN1CCC(CC1)OC(=O)NC1=CC=CC=C1C1=CC=CC=C1)C(=O)C1=CC=C(CN2CCC(CC2)C(N)=O)C=C1
433,rifamycin,NDA,2018,rifamycin,DB11753,approved; investigational,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C)C(O)=C4C(O)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C=C(O)C4=C3C2=O
434,glasdegib,NDA,2018,glasdegib,DB11978,approved; investigational,CN1CC[C@H](C[C@@H]1C1=NC2=CC=CC=C2N1)NC(=O)NC1=CC=C(C=C1)C#N
435,larotrectinib,NDA,2018,larotrectinib,DB14723,approved; investigational,O[C@H]1CCN(C1)C(=O)NC1=C2N=C(C=CN2N=C1)N1CCC[C@@H]1C1=C(F)C=CC(F)=C1
436,amifampridine,NDA,2018,amifampridine,DB11640,approved; investigational,NC1=CC=NC=C1N
437,gilteritinib,NDA,2018,gilteritinib,DB12141,approved; investigational,CCC1=C(NC2CCOCC2)N=C(NC2=CC=C(N3CCC(CC3)N3CCN(C)CC3)C(OC)=C2)C(=N1)C(N)=O
438,prucalopride,NDA,2018,prucalopride,DB06480,approved,COCCCN1CCC(CC1)NC(=O)C1=C2OCCC2=C(N)C(Cl)=C1
439,triclabendazole,NDA,2019,triclabendazole,DB12245,approved; investigational,CSC1=NC2=C(N1)C=C(Cl)C(OC1=CC=CC(Cl)=C1Cl)=C2
440,brexanolone,NDA,2019,brexanolone,DB11859,approved; investigational,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)C(C)=O
441,solriamfetol,NDA,2019,solriamfetol,DB14754,approved,N[C@@H](COC(N)=O)CC1=CC=CC=C1
442,siponimod,NDA,2019,siponimod,DB12371,approved; investigational,CCC1=CC(=CC=C1CN1CC(C1)C(O)=O)C(\C)=N\OCC1=CC=C(C2CCCCC2)C(=C1)C(F)(F)F
443,erdafitinib,NDA,2019,erdafitinib,DB12147,approved; investigational,COC1=CC(=CC(OC)=C1)N(CCNC(C)C)C1=CC=C2N=CC(=NC2=C1)C1=CN(C)N=C1
444,alpelisib,NDA,2019,alpelisib,DB12015,approved; investigational,CC1=C(SC(NC(=O)N2CCC[C@H]2C(N)=O)=N1)C1=CC(=NC=C1)C(C)(C)C(F)(F)F
445,bremelanotide,NDA,2019,bremelanotide,DB11653,approved; investigational,CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@H](CC2=CNC3=CC=CC=C23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CN=CN2)NC1=O)C(O)=O
446,selinexor,NDA,2019,selinexor,DB11942,approved; investigational,FC(F)(F)C1=CC(=CC(=C1)C1=NN(\C=C/C(=O)NNC2=NC=CN=C2)C=N1)C(F)(F)F
447,ferric maltol,NDA,2019,ferric maltol,DB15598,approved,[Fe+3].CC1=C([O-])C(=O)C=CO1.CC1=C([O-])C(=O)C=CO1.CC1=C([O-])C(=O)C=CO1
448,darolutamide,NDA,2019,darolutamide,DB12941,approved; investigational,C[C@@H](CN1C=CC(=N1)C1=CC=C(C#N)C(Cl)=C1)NC(=O)C1=NNC(=C1)C(C)O
449,pexidartinib,NDA,2019,pexidartinib,DB12978,approved; investigational,FC(F)(F)C1=CC=C(CNC2=NC=C(CC3=CNC4=NC=C(Cl)C=C34)C=C2)C=N1
450,pitolisant,NDA,2019,pitolisant,DB11642,approved; investigational,ClC1=CC=C(CCCOCCCN2CCCCC2)C=C1
451,pretomanid,NDA,2019,pretomanid,DB05154,approved,[O-][N+](=O)C1=CN2C[C@@H](COC2=N1)OCC1=CC=C(OC(F)(F)F)C=C1
452,entrectinib,NDA,2019,entrectinib,DB11986,approved; investigational,CN1CCN(CC1)C1=CC=C(C(=O)NC2=NNC3=CC=C(CC4=CC(F)=CC(F)=C4)C=C23)C(NC2CCOCC2)=C1
453,fedratinib,NDA,2019,fedratinib,DB12500,approved; investigational,CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C
454,upadacitinib,NDA,2019,upadacitinib,DB15091,approved; investigational,CC[C@@H]1CN(C[C@@H]1C1=CN=C2C=NC3=C(C=CN3)N12)C(=O)NCC(F)(F)F
455,lefamulin,NDA,2019,lefamulin,DB12825,approved; investigational,[H][C@@]12C(=O)CC[C@]11CCC(C)[C@@]2(C)[C@@H](C[C@@](C)(C=C)[C@@H](O)[C@@H]1C)OC(=O)CS[C@@H]1CC[C@@H](N)C[C@H]1O
456,istradefylline,NDA,2019,istradefylline,DB11757,approved; investigational,[H]\C(=C(\[H])C1=CC(OC)=C(OC)C=C1)C1=NC2=C(N1C)C(=O)N(CC)C(=O)N2CC
457,tenapanor,NDA,2019,tenapanor,DB11761,approved; investigational,CN1C[C@@H](C2=CC(=CC=C2)S(=O)(=O)NCCOCCOCCNC(=O)NCCCCNC(=O)NCCOCCOCCNS(=O)(=O)C2=CC(=CC=C2)[C@@H]2CN(C)CC3=C2C=C(Cl)C=C3Cl)C2=C(C1)C(Cl)=CC(Cl)=C2
458,trifarotene,NDA,2019,trifarotene,DB12808,approved; investigational,CC(C)(C)C1=CC(=CC=C1N1CCCC1)C1=CC(=CC=C1OCCO)C1=CC=C(C=C1)C(O)=O
459,afamelanotide,NDA,2019,afamelanotide,DB04931,approved; investigational,CCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(N)=O
460,lasmiditan,NDA,2019,lasmiditan,DB11732,approved; investigational,CN1CCC(CC1)C(=O)C1=CC=CC(NC(=O)C2=C(F)C=C(F)C=C2F)=N1
461,zanubrutinib,NDA,2019,zanubrutinib,DB15035,approved; investigational,NC(=O)C1=C2NCC[C@@H](C3CCN(CC3)C(=O)C=C)N2N=C1C1=CC=C(OC2=CC=CC=C2)C=C1
462,cefiderocol,NDA,2019,cefiderocol,DB14879,approved; investigational,[H][C@]12SCC(C[N+]3(CCNC(=O)C4=C(Cl)C(O)=C(O)C=C4)CCCC3)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=CSC(N)=N1)C([O-])=O
463,cenobamate,NDA,2019,cenobamate,DB06119,approved; investigational,NC(=O)O[C@@H](CN1N=CN=N1)C1=C(Cl)C=CC=C1
464,voxelotor,NDA,2019,voxelotor,DB14975,approved; investigational,CC(C)N1N=CC=C1C1=C(COC2=CC=CC(O)=C2C=O)C=CC=N1
465,lumateperone,NDA,2019,lumateperone,DB06077,approved; investigational,[H][C@]12CCN(CCCC(=O)C3=CC=C(F)C=C3)C[C@@]1([H])C1=CC=CC3=C1N2CCN3C
466,lemborexant,NDA,2019,lemborexant,DB11951,approved; investigational,CC1=NC=C(OC[C@]2(C[C@H]2C(=O)NC2=NC=C(F)C=C2)C2=CC=CC(F)=C2)C(C)=N1
467,ubrogepant,NDA,2019,ubrogepant,DB15328,approved; investigational,C[C@@H]1[C@@H](C[C@H](NC(=O)C2=CN=C3C[C@]4(CC3=C2)C(=O)NC2=NC=CC=C42)C(=O)N1CC(F)(F)F)C1=CC=CC=C1
468,avapritinib,NDA,2020,avapritinib,DB15233,approved; investigational,CN1C=C(C=N1)C1=CN2N=CN=C(N3CCN(CC3)C3=NC=C(C=N3)[C@@](C)(N)C3=CC=C(F)C=C3)C2=C1
469,tazemetostat,NDA,2020,tazemetostat,DB12887,approved; investigational,CCN(C1CCOCC1)C1=C(C)C(=CC(=C1)C1=CC=C(CN2CCOCC2)C=C1)C(=O)NCC1=C(C)C=C(C)NC1=O
470,lactitol,NDA,2020,lactitol,DB12942,approved; investigational,OC[C@H](O)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)CO
471,bempedoic acid,NDA,2020,bempedoic acid,DB11936,approved; investigational,CC(C)(CCCCCC(O)CCCCCC(C)(C)C(O)=O)C(O)=O
472,amisulpride,NDA,2020,amisulpride,DB06288,approved; investigational,CCN1CCCC1CNC(=O)C1=CC(=C(N)C=C1OC)S(=O)(=O)CC
473,rimegepant,NDA,2020,rimegepant,DB12457,approved; investigational,N[C@H]1[C@@H](CC[C@@H](OC(=O)N2CCC(CC2)N2C(=O)NC3=NC=CC=C23)C2=C1C=CC=N2)C1=C(F)C(F)=CC=C1
474,osilodrostat,NDA,2020,osilodrostat,DB11837,approved; investigational,FC1=C(C=CC(=C1)C#N)[C@H]1CCC2=CN=CN12
475,ozanimod,NDA,2020,ozanimod,DB12612,approved; investigational,CC(C)OC1=C(C=C(C=C1)C1=NC(=NO1)C1=C2CC[C@H](NCCO)C2=CC=C1)C#N
476,selumetinib,NDA,2020,selumetinib,DB11689,approved; investigational,CN1C=NC2=C(F)C(NC3=C(Cl)C=C(Br)C=C3)=C(C=C12)C(=O)NOCCO
477,pemigatinib,NDA,2020,pemigatinib,DB15102,approved; investigational,CCN1C(=O)N(CC2=CN=C3NC(CN4CCOCC4)=CC3=C12)C1=C(F)C(OC)=CC(OC)=C1F
478,tucatinib,NDA,2020,tucatinib,DB11652,approved; investigational,CC1=CC(NC2=NC=NC3=CC=C(NC4=NC(C)(C)CO4)C=C23)=CC=C1OC1=CC2=NC=NN2C=C1
479,opicapone,NDA,2020,opicapone,DB11632,approved; investigational,CC1=C(C2=NOC(=N2)C2=CC(=C(O)C(O)=C2)[N+]([O-])=O)C(Cl)=[N+]([O-])C(C)=C1Cl
480,capmatinib,NDA,2020,capmatinib,DB11791,approved; investigational,CNC(=O)C1=C(F)C=C(C=C1)C1=NN2C(CC3=CC4=C(C=C3)N=CC=C4)=CN=C2N=C1
481,selpercatinib,NDA,2020,selpercatinib,DB15685,approved; investigational,COC1=NC=C(CN2C3CC2CN(C3)C2=CC=C(C=N2)C2=CC(OCC(C)(C)O)=CN3N=CC(C#N)=C23)C=C1
482,ripretinib,NDA,2020,ripretinib,DB14840,approved,CCN1C(=O)C(=CC2=C1C=C(NC)N=C2)C1=C(Br)C=C(F)C(NC(=O)NC2=CC=CC=C2)=C1
483,artesunate,NDA,2020,artesunate,DB09274,approved; investigational,[H][C@@]12CC[C@@H](C)[C@]3([H])CC[C@@]4(C)OO[C@@]13[C@]([H])(O[C@@H](OC(=O)CCC(O)=O)[C@@H]2C)O4
484,lurbinectedin,NDA,2020,lurbinectedin,DB12674,approved; investigational,[H][C@@]12[C@@H]3SC[C@]4(NCCC5=C4NC4=CC=C(OC)C=C54)C(=O)OC[C@H](N1[C@@H](O)[C@@H]1CC4=CC(C)=C(OC)C(O)=C4[C@@]2([H])N1C)C1=C2OCOC2=C(C)C(OC(C)=O)=C31
485,triheptanoin,NDA,2020,triheptanoin,DB11677,approved; investigational,CCCCCCC(=O)OCC(COC(=O)CCCCCC)OC(=O)CCCCCC
486,remimazolam,NDA,2020,remimazolam,DB12404,approved; investigational,COC(=O)CC[C@@H]1N=C(C2=CC=CC=N2)C2=CC(Br)=CC=C2N2C(C)=CN=C12
487,fostemsavir,NDA,2020,fostemsavir,DB11796,approved; investigational,COC1=CN=C(N2C=NC(C)=N2)C2=C1C(=CN2COP(O)(O)=O)C(=O)C(=O)N1CCN(CC1)C(=O)C1=CC=CC=C1
488,abametapir,NDA,2020,abametapir,DB11932,approved; investigational,CC1=CC=C(N=C1)C1=CC=C(C)C=N1
489,nifurtimox,NDA,2020,nifurtimox,DB11820,approved; investigational,CC1CS(=O)(=O)CCN1\N=C\C1=CC=C(O1)[N+]([O-])=O
490,risdiplam,NDA,2020,risdiplam,DB15305,approved; investigational,CC1=CN2N=C(C=C(C)C2=N1)C1=CC(=O)N2C=C(C=CC2=N1)N1CCNC2(CC2)C1
491,oliceridine,NDA,2020,oliceridine,DB14881,approved; investigational,COC1=C(CNCC[C@]2(CCOC3(CCCC3)C2)C2=NC=CC=C2)SC=C1
492,clascoterone,NDA,2020,clascoterone,DB12499,approved; investigational,[H][C@@]12CC[C@](OC(=O)CC)(C(=O)CO)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
493,pralsetinib,NDA,2020,pralsetinib,DB15822,approved; investigational,CO[C@]1(CC[C@@H](CC1)C1=NC(NC2=NNC(C)=C2)=CC(C)=N1)C(=O)N[C@@H](C)C1=CC=C(N=C1)N1C=C(F)C=N1
494,remdesivir,NDA,2020,remdesivir,DB14761,approved; investigational,CCC(CC)COC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@](C#N)([C@H](O)[C@@H]1O)C1=CC=C2N1N=CN=C2N)OC1=CC=CC=C1
495,lonafarnib,NDA,2020,lonafarnib,DB06448,approved; investigational,NC(=O)N1CCC(CC(=O)N2CCC(CC2)[C@H]2C3=C(CCC4=C2C(Br)=CC(Cl)=C4)C=C(Br)C=N3)CC1
496,setmelanotide,NDA,2020,setmelanotide,DB11700,approved; investigational,[H]N([H])C(=O)[C@@H]1CSSC[C@H](N([H])C(=O)[C@H](CCCN=C(N([H])[H])N([H])[H])N([H])C(C)=O)C(=O)N[C@H](C)C(=O)N[C@@H](CC2=CN=CN2[H])C(=O)N[C@H](CC2=CC=CC=C2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC2=CN([H])C3=CC=CC=C23)C(=O)N1
497,berotralstat,NDA,2020,berotralstat,DB15982,approved,NCC1=CC(=CC=C1)N1N=C(C=C1C(=O)NC1=CC(=CC=C1F)[C@H](NCC1CC1)C1=CC=CC(=C1)C#N)C(F)(F)F
498,tirbanibulin,NDA,2020,tirbanibulin,DB06137,approved; investigational,O=C(CC1=CC=C(C=N1)C1=CC=C(OCCN2CCOCC2)C=C1)NCC1=CC=CC=C1
499,relugolix,NDA,2020,relugolix,DB11853,approved; investigational,CONC(=O)NC1=CC=C(C=C1)C1=C(CN(C)C)C2=C(S1)N(CC1=C(F)C=CC=C1F)C(=O)N(C2=O)C1=CC=C(OC)N=N1
500,vibegron,NDA,2020,vibegron,DB14895,approved; investigational,[H][C@@]1(CC[C@@H](CC2=CC=C(NC(=O)[C@@H]3CCC4=NC=CC(=O)N34)C=C2)N1)[C@H](O)C1=CC=CC=C1
501,vericiguat,NDA,2021,vericiguat,DB15456,approved; investigational,COC(=O)NC1=C(N)N=C(N=C1N)C1=NN(CC2=CC=CC=C2F)C2=C1C=C(F)C=N2
502,voclosporin,NDA,2021,voclosporin,DB11693,approved; investigational,[H][C@@]1([C@H](O)[C@H](C)C\C=C\C=C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC1=O)C(C)C
503,tepotinib,NDA,2021,tepotinib,DB15133,approved; investigational,CN1CCC(COC2=CN=C(N=C2)C2=CC(CN3N=C(C=CC3=O)C3=CC(=CC=C3)C#N)=CC=C2)CC1
504,umbralisib,NDA,2021,umbralisib,DB14989,approved; investigational,CC(C)OC1=C(F)C=C(C=C1)C1=NN([C@@H](C)C2=C(C3=CC=CC(F)=C3)C(=O)C3=CC(F)=CC=C3O2)C2=C1C(N)=NC=N2
505,trilaciclib,NDA,2021,trilaciclib,DB15442,approved; investigational,CN1CCN(CC1)C1=CN=C(NC2=NC3=C(C=C4N3C3(CCCCC3)CNC4=O)C=N2)C=C1
506,fosdenopterin,NDA,2021,fosdenopterin,DB16628,approved,[H][C@@]12COP(O)(=O)O[C@]1([H])C(O)(O)[C@]1([H])NC3=C(NC(N)=NC3=O)N[C@]1([H])O2
507,melphalan flufenamide,NDA,2021,melphalan flufenamide,DB16627,approved; withdrawn,CCOC(=O)[C@H](CC1=CC=C(F)C=C1)NC(=O)[C@@H](N)CC1=CC=C(C=C1)N(CCCl)CCCl
508,tivozanib,NDA,2021,tivozanib,DB11800,approved; investigational,COC1=C(OC)C=C2C(OC3=CC(Cl)=C(NC(=O)NC4=NOC(C)=C4)C=C3)=CC=NC2=C1
509,ponesimod,NDA,2021,ponesimod,DB12016,approved; investigational,CCC\N=C1/S\C(=C/C2=CC=C(OC[C@H](O)CO)C(Cl)=C2)C(=O)N1C1=CC=CC=C1C
510,viloxazine,NDA,2021,viloxazine,DB09185,approved; investigational; withdrawn,CCOC1=CC=CC=C1OCC1CNCCO1
511,sotorasib,NDA,2021,sotorasib,DB15569,approved; investigational,CC(C)C1=NC=CC(C)=C1N1C(=O)N=C(N2CCN(C[C@@H]2C)C(=O)C=C)C2=CC(F)=C(N=C12)C1=C(O)C=CC=C1F
512,infigratinib,NDA,2021,infigratinib,DB11886,approved; investigational,CCN1CCN(CC1)C1=CC=C(NC2=CC(=NC=N2)N(C)C(=O)NC2=C(Cl)C(OC)=CC(OC)=C2Cl)C=C1
513,ibrexafungerp,NDA,2021,ibrexafungerp,DB12471,approved; investigational,[H][C@]12CC[C@@]3([H])[C@@]4(C)COC[C@@]3(C[C@H]([C@@H]4OC[C@](C)(N)C(C)(C)C)N3N=CN=C3C3=CC=NC=C3)C1=CC[C@@]1(C)[C@H](C(O)=O)[C@](C)(CC[C@]21C)[C@H](C)C(C)C
514,finerenone,NDA,2021,finerenone,DB16165,approved; investigational,CCOC1=NC=C(C)C2=C1[C@H](C1=CC=C(C=C1OC)C#N)C(C(N)=O)=C(C)N2
515,fexinidazole,NDA,2021,fexinidazole,DB12265,approved; investigational,CSC1=CC=C(OCC2=NC=C(N2C)[N+]([O-])=O)C=C1
516,belumosudil,NDA,2021,belumosudil,DB16703,approved; investigational,CC(C)NC(=O)COC1=CC=CC(=C1)C1=NC2=C(C=CC=C2)C(NC2=CC=C3NN=CC3=C2)=N1
517,odevixibat,NDA,2021,odevixibat,DB16261,approved; investigational,CCCCC1(CCCC)CN(C2=CC=CC=C2)C2=CC(SC)=C(OCC(=O)N[C@@H](C(=O)N[C@@H](CC)C(O)=O)C3=CC=C(O)C=C3)C=C2S(=O)(=O)N1
518,belzutifan,NDA,2021,belzutifan,DB15463,approved; investigational,CS(=O)(=O)C1=CC=C(OC2=CC(=CC(F)=C2)C#N)C2=C1[C@H](O)[C@H](F)[C@@H]2F
519,difelikefalin,NDA,2021,difelikefalin,DB11938,approved; investigational,CC(C)C[C@@H](NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](N)CC1=CC=CC=C1)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O
520,mobocertinib,NDA,2021,mobocertinib,DB16390,approved; investigational,COC1=C(NC2=NC=C(C(=O)OC(C)C)C(=N2)C2=CN(C)C3=C2C=CC=C3)C=C(NC(=O)C=C)C(=C1)N(C)CCN(C)C
521,atogepant,NDA,2021,atogepant,DB16098,approved; investigational,C[C@@H]1[C@@H](C[C@H](NC(=O)C2=CN=C3C[C@]4(CC3=C2)C(=O)NC2=C4C=CC=N2)C(=O)N1CC(F)(F)F)C1=C(F)C(F)=CC=C1F
522,maralixibat,NDA,2021,maralixibat,DB16226,approved; investigational,CCCCC1(CCCC)CS(=O)(=O)C2=CC=C(C=C2[C@H]([C@H]1O)C1=CC=C(OCC2=CC=C(C[N+]34CCN(CC3)CC4)C=C2)C=C1)N(C)C
523,avacopan,NDA,2021,avacopan,DB15011,approved; investigational,CC1=CC=C(NC(=O)[C@H]2CCCN([C@H]2C2=CC=C(NC3CCCC3)C=C2)C(=O)C2=C(F)C=CC=C2C)C=C1C(F)(F)F
524,asciminib,NDA,2021,asciminib,DB12597,approved; investigational,O[C@@H]1CCN(C1)C1=C(C=C(C=N1)C(=O)NC1=CC=C(OC(F)(F)Cl)C=C1)C1=CC=NN1
525,maribavir,NDA,2021,maribavir,DB06234,approved; investigational,CC(C)NC1=NC2=CC(Cl)=C(Cl)C=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O
526,pafolacianine,NDA,2021,pafolacianine,DB15413,approved; investigational,CC1(C)\C(=C/C=C2\CCCC(\C=C\C3=[N+](CCCCS(O)(=O)=O)C4=C(C=C(C=C4)S([O-])(=O)=O)C3(C)C)=C2OC2=CC=C(C[C@H](NC(=O)C3=CC=C(NCC4=CN=C5N=C(N)NC(=O)C5=N4)C=C3)C(O)=O)C=C2)N(CCCCS(O)(=O)=O)C2=C1C=C(C=C2)S(O)(=O)=O
527,tiludronate disodium,NDA,1997,tiludronate,,,[Na+].[Na+].O[P]([O-])(=O)C(Sc1ccc(Cl)cc1)[P](O)([O-])=O
528,ardeparin sodium,NDA,1997,ardeparin,DB00407,approved; investigational; withdrawn,CC(=O)NC1C(O)OC(CO[S](O)(=O)=O)C(OC2OC(C(OC3OC(CO)C(OC4OC(C(O)C(O)C4O[S](O)(=O)=O)C(O)=O)C(O[S](O)(=O)=O)C3N[S](O)(=O)=O)C(O)C2O[S](O)(=O)=O)C(O)=O)C1O
529,mibefradil dihydrochloride,NDA,1997,mibefradil,,,COCC(=O)O[C@]1(CCN(C)CCCc2[nH]c3ccccc3n2)CCc4cc(F)ccc4[C@@H]1C(C)C
530,lepirudin,NDA,1998,lepirudin,,,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc4[nH]cnc4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc5ccccc5)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N6CCC[C@H]6C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc7ccc(O)cc7)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O
531,risedronate sodium,NDA,1998,risedronate,,,OC(Cc1cccnc1)([P](O)(O)=O)[P](O)(O)=O
532,eptifibatide,NDA,1998,eptifibatide,,,NC(N)=NCCCCC1NC(=O)CCSSCC(NC(=O)C2CCCN2C(=O)C(Cc3c[nH]c4ccccc34)NC(=O)C(CC(O)=O)NC(=O)CNC1=O)C(N)=O
533,fomivirsen sodium,NDA,1998,fomivirsen,,,CC1=CN([C@H]2C[C@H](O[P](O)(=S)OC[C@H]3O[C@H](C[C@@H]3O[P](O)(=S)OC[C@H]4O[C@H](C[C@@H]4O[P](O)(=S)OC[C@H]5O[C@H](C[C@@H]5O[P](O)(=S)OC[C@H]6O[C@H](C[C@@H]6O[P](O)(=S)OC[C@H]7O[C@H](C[C@@H]7O[P](O)(=S)OC[C@H]8O[C@H](C[C@@H]8O[P](O)(=S)OC[C@H]9O[C@H](C[C@@H]9O[P](O)(=S)OC[C@H]%10O[C@H](C[C@@H]%10O[P](O)(=S)OC[C@H]%11O[C@H](C[C@@H]%11O[P](O)(=S)OC[C@H]%12O[C@H](C[C@@H]%12O[P](O)(=S)OC[C@H]%13O[C@H](C[C@@H]%13O[P](O)(=S)OC[C@H]%14O[C@H](C[C@@H]%14O)n%15cnc%16C(=O)NC(=Nc%15%16)N)N%17C=CC(=NC%17=O)N)n%18cnc%19C(=O)N=C(N)Nc%18%19)N%20C=C(C)C(=O)NC%20=O)N%21C=C(C)C(=O)NC%21=O)N%22C=CC(=NC%22=O)N)N%23C=C(C)C(=O)NC%23=O)N%24C=C(C)C(=O)NC%24=O)N%25C=CC(=NC%25=O)N)N%26C=C(C)C(=O)NC%26=O)N%27C=C(C)C(=O)NC%27=O)N%28C=CC(=NC%28=O)N)[C@@H](CO[P](O)(=S)O[C@H]%29C[C@@H](O[C@@H]%29CO[P](O)(=S)O[C@H]%30C[C@@H](O[C@@H]%30CO[P](O)(=S)O[C@H]%31C[C@@H](O[C@@H]%31CO[P](O)(=S)O[C@H]%32C[C@@H](O[C@@H]%32CO[P](O)(=S)O[C@H]%33C[C@@H](O[C@@H]%33CO[P](O)(=S)O[C@H]%34C[C@@H](O[C@@H]%34CO[P](O)(=S)O[C@H]%35C[C@@H](O[C@@H]%35CO[P](O)(=S)O[C@H]%36C[C@@H](O[C@@H]%36CO)n%37cnc%38C(=O)NC(=Nc%37%38)N)N%39C=CC(=NC%39=O)N)n%40cnc%41C(=O)NC(=Nc%40%41)N)N%42C=C(C)C(=O)NC%42=O)N%43C=C(C)C(=O)NC%43=O)N%44C=C(C)C(=O)NC%44=O)n%45cnc%46C(=O)NC(=Nc%45%46)N)N%47C=CC(=NC%47=O)N)O2)C(=O)NC1=O
534,sodium ferric gluconate complex,NDA,1999,ferric gluconate complex,,,Did not work
535,pemirolast potassium,NDA,1999,pemirolast potassium,,,[K+].CC1=CC=CN2C(=O)C(=CN=C12)c3[n-]nnn3
536,gemtuzumab ozogamicin,NDA,2000,gemtuzumab ozogamicin,,,Did not work
537,colesevelam hydrochloride,NDA,2000,colesevelam,DB00930,approved,Did not work
538,triptorelin pamoate,NDA,2000,triptorelin pamoate,,,N.CC(C)CC(NC(=O)C(CC1=CCc2ccccc12)NC(=O)C(Cc3ccc(O)cc3)NC(=O)C(CO)NC(=O)C(CCc4ccccc4NC=C)NC(=O)C(CC(=O)C5CCC(=O)N5)Cc6[nH]cnc6)C(=O)NC(CCCNC(N)=N)C(=O)CN7CCCC7C(=O)NCC(N)=O.OC(=O)c8cc9ccccc9c(Cc%10c(O)c(cc%11ccccc%10%11)C(O)=O)c8O
539,tinzaparin sodium,NDA,2000,tinzaparin,DB06822,approved,Did not work
540,unoprostone isopropyl,NDA,2000,unoprostone isopropyl,,,Did not work
541,perflutren lipid microsphere,NDA,2001,perflutren lipid microsphere,,,Did not work
542,nesiritide,NDA,2001,nesiritide,,,Did not work
543,cefditoren pivoxil,NDA,2001,cefditoren pivoxil,,,Did not work
544,olmesartan medoxomil,NDA,2002,olmesartan medoxomil,,,CCCc1nc(c(n1Cc2ccc(cc2)c3ccccc3c4n[nH]nn4)C(=O)OCC5=C(C)OC(=O)O5)C(C)(C)O
545,sodium oxybate,NDA,2002,oxybate,,,Did not work
546,icodextrin,NDA,2002,icodextrin,DB00702,approved; investigational,OC[C@H]1OC(O[C@H]2[C@H](O)[C@@H](O)C(O[C@@H]2CO)O[C@H]3[C@H](O)[C@@H](O)[C@@H](O)O[C@@H]3CO)[C@H](O)[C@@H](O)[C@@H]1O
547,enfuvirtide,NDA,2003,enfuvirtide,,,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1[nH]cnc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(C)=O)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc5c[nH]c6ccccc56)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc7c[nH]c8ccccc78)C(=O)N[C@@H](Cc9ccccc9)C(N)=O
548,human secretin,NDA,2004,human secretin,,,Did not work
549,pentetate calcium trisodium,NDA,2004,pentetate,,,Did not work
550,pentetate zinc trisodium,NDA,2004,pentetate zinc,,,[Zn++]|1|OC(=O)CN(CCN(CC(O)=O)CC(O|1)=O)CCN(CC(O)=O)CC(O)=O
551,lanthanum carbonate hydrate,NDA,2004,lanthanum carbonate hydrate,,,O.[La+3].[La+3].[O-]C([O-])=O.[O-]C([O-])=O.[O-]C([O-])=O
552,gadobenate dimeglumine,NDA,2004,gadobenate dimeglumine,,,[Gd+3].CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.[H+].[H+].[O-]C(=O)CN(CCN(CC([O-])=O)CC([O-])=O)CCN(CC([O-])=O)C(COCc1ccccc1)C([O-])=O
553,trypan blue,NDA,2004,trypan blue,,,[Na+].[Na+].[Na+].[Na+].Cc1cc(ccc1N\N=C/2C(=O)c3c(N)cc(cc3C=C2[S]([O-])(=O)=O)[S]([O-])(=O)=O)c4ccc(N\N=C/5C(=O)c6c(N)cc(cc6C=C5[S]([O-])(=O)=O)[S]([O-])(=O)=O)c(C)c4
554,pegaptanib sodium,NDA,2004,pegaptanib,,,Did not work
555,clofarbine,NDA,2004,clofarbine,,,Did not work
556,exenatide,NDA,2005,exenatide,,,Did not work
557,kunecatechins,NDA,2006,kunecatechins,,,Did not work
558,fosaprepitant dimeglumine,NDA,2008,fosaprepitant dimeglumine,,,C[NH2+]C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.C[NH2+]C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.C[C@@H](O[C@H]1OCCN(CC2=NC(=O)N(N2)[P]([O-])([O-])=O)[C@H]1c3ccc(F)cc3)c4cc(cc(c4)C(F)(F)F)C(F)(F)F
559,gadoxetate disodium,NDA,2008,gadoxetate,,,[Gd+3].CCOc1ccc(CC(CN(CCN(CC(O)=O)CC(O)=O)CC(O)=O)N(CC(O)=O)CC(O)=O)cc1
560,gadofosveset trisodium,NDA,2008,gadofosveset,,,Did not work
561,liraglutide,NDA,2010,liraglutide,,,Did not work
562,lucinactant,NDA,2012,lucinactant,,,Did not work
563,peginesatide,NDA,2012,peginesatide,,,Did not work
564,omacetaxine mepesuccinate,NDA,2012,omacetaxine,,,Did not work
565,teduglutideÂ (rDNAÂ origin),NDA,2012,teduglutide (rDNA origin),,,Did not work
566,crofelemer,NDA,2012,crofelemer,DB04941,approved,Did not work
567,gadoterate meglumine,NDA,2013,gadoterate meglumine,,,[Gd+3].CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC(=O)CN1CCN(CCN(CCN(CC1)CC([O-])=O)CC([O-])=O)CC([O-])=O
568,dimethyl fumarate,NDA,2013,dimethyl,,,CC
569,dalbavancin,NDA,2014,dalbavancin,DB06219,approved; investigational,CN[C@H]1C(=O)N[C@@H]2Cc3ccc(Oc4cc5cc(Oc6ccc(cc6Cl)[C@@H](O)[C@@H]7NC(=O)[C@H](NC(=O)[C@@H]5NC(=O)[C@@H](NC2=O)c8cc(Oc9cc1ccc9O)cc(O)c8Cl)c%10ccc(O)c(c%10)c%11c(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]%12O)cc(O)cc%11[C@@H](NC7=O)C(=O)NCCCN(C)C)c4O[C@@H]%13O[C@@H]([C@@H](O)[C@H](O)[C@H]%13NC(=O)CCCCCCCCC(C)C)C(O)=O)cc3
570,sulfur hexafluoride lipid-type A microspheres,NDA,2014,sulfur hexafluoride lipid-type A microspheres,,,Did not work
571,patiromer,NDA,2015,patiromer,DB09263,approved; investigational,Did not work
572,defibrotide sodium,NDA,2016,defibrotide,,,Did not work
573,eteplirsen,NDA,2016,eteplirsen,,,Did not work
574,nusinersen,NDA,2016,nusinersen,,,Did not work
575,abaloparatide,NDA,2017,abaloparatide,,,Did not work
576,angiotensin II,NDA,2017,angiotensin II,,,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(=O)N[C@@H](Cc2[nH]cnc2)C(=O)N3CCC[C@H]3C(=O)N[C@@H](Cc4ccccc4)C(O)=O
577,sodium zirconium cyclosilicate,NDA,2018,zirconium cyclosilicate,,,Did not work
578,fish oil triglycerides,NDA,2018,fish oil triglycerides,,,Did not work
579,patisiran,NDA,2018,patisiran,,,Did not work
580,inotersen,NDA,2018,inotersen,,,Did not work
581,tafamidis meglumine,NDA,2019,tafamidis meglumine,,,Did not work
582,air polymer-type A,NDA,2019,air polymer-type A,,,Did not work
583,givosiran,NDA,2019,givosiran,,,Did not work
584,golodirsen,NDA,2019,golodirsen,,,Did not work
585,Brilliant Blue G Ophthalmic Solution,NDA,2019,Brilliant Blue G Ophthalmic Solution,,,Did not work
586,viltolarsen,NDA,2020,viltolarsen,,,Did not work
587,lumasiran,NDA,2020,lumasiran,,,Did not work
588,casimersen,NDA,2021,casimersen,,,Did not work
589,dasiglucagon,NDA,2021,dasiglucagon,,,Did not work
590,pegcetacoplan,NDA,2021,pegcetacoplan,,,Did not work
591,vosoritide,NDA,2021,vosoritide,,,Did not work
592,inclisiran,NDA,2021,inclisiran,,,Did not work
